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Upcoming Events
January 8, Thursday, 4:00 P.M.
The Rehfuss Lecture: Nobel laureate Gertrude Elion, D.Sc.
will speak on "Challenges and Rewards of Pharmaceutical Research"
Connelly Conference Hall, Bluemle Building
January 21, Wednesday
"Beef and Brew" to greet first yearstudents
January 22, Thursday
Alumni Executive Committee Meeting
January 31—February 7
Ski Meeting, Big Sky, Montana
February 5, Thursday
State of the University and Medical College
Presentation at 5:00 P.M.—see page 31
February 26, Thursday
Alumni Executive Committee Meeting

Reunion Chair John M. Fenlin Jr.
'63 and Class Agent Phillip J.
Marone 'S7 at the October 8
Leadership Dinner,
the kickoff for the 50th
Annual Giving Campaign

March I, Sunday
Alumni Reception at the meeting of the American Academy of
Dermatology, Orlando, Florida
March 13, Friday
Parents' Day for the sophomore class and their families
March 20, Friday
Alumni Reception at the meeting of the American Academy of
Orthopaedic Surgeons, New Orleans
April 3, Friday
Alumni Reception at the meeting of the American College of

Class Agents Bret R. Sokoloff '96

Physicians, San Diego

and Raj K. Sinha '89

May 10, Sunday
Alumni Reception at the meeting of the American College of
Agents for the Class of '58
Peter Amadio Jr. and
Herbert G. Hopwood Jr.

Obstetricians and Gynecologists, New Orleans
May 28, Thursday
Commencement
May 31, Sunday
Alumni Reception at the meeting of the American Psychiatric
Association, Toronto
June I, Monday
Alumni Reception at the meeting of the American Urological
Association, San Diego
Reunion Weekend '98
June 5, Friday, Alumni Banquet
June 6, Saturday, Clinic Presentations, Reunion Parties
June 7, Sunday, Farewell Brunch
June 7-11
Trip to Bermuda—see page 30

John J. Gartland S'44 and
Stacy L. Rollins Jr. J'44
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This issue of the Bulletin heralds two anniversaries: the 50th Annual Giving Campaign
(see page 4) and the 75th year of the Bulletin itself (see page 17).
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50th YEAR of ANNUAL GIVING
Annual Giving Celebrates a Half-Century of Strengthening Jefferson
s Jefferson Medical College celebrates the 50th anniversary of its Alumni
Annual Giving Campaign, a fund raising effort that has been recognized
repeatedly as one of the finest institutional campaigns in the country, it
seems timely to not only recall how this effort came into being, but also to
record and celebrate its growth and significance for Jefferson. Money
contributed in the Alumni Annual Giving Campaigns gives the Dean access
to indispensable discretionary funds which allow him to take advantage of
academic opportunities and to meet academic emergencies.
This additional money allows the Dean to recruit and retain
the best faculty, and to support research by young investigators while they are competing for major National Institutes
of Health grant funding. Annual Giving also provides
additional student financial aid and emergency funds for
students. Since 1988, contributors to Alumni Annual Giving
have donated $2,425,443 to student financial aid.
Annual Giving provides the Dean with over one million
dollars in unrestricted funds. In describing the academic
opportunities and academic emergencies for which these
funds are needed, Dean Joseph S. Gonnella says "Some of
Dr. Cies'.
these unanticipated situations include the programs of the
Kimmel Cancer Center, support for the development of our pool of primary
care physicians, the recruitment of department chairs and faculty, the
remodeling of research space and the purchase of specialized equipment
needs for researchers, support for the Alumni Professorship in Family
Medicine, emergency funds for medical students and for providing
specialized transportation needs for students to implement
new curricular projects, the refurbishing of educational
facilities, such as providing classroom audiovisual support
and computer facilities, and support for students to work
with faculty in the development of computer assisted
materials."
The original stimulus for Jefferson to initiate Alumni Annual
Giving can be traced to Samuel D. Gross, Class of 1828. In a
March 11, 1871 address to the fledgling Alumni Association
of Jefferson Medical College on its first anniversary, Dr.
Gross, Professor of Surgery and President of the newly
Dr. Fetter
formed Alumni Association said "Measures should be
adopted to endow scholarships and professorships. Some of
our alumni are men of large means and they could therefore well afford to
aid in such a praiseworthy enterprise." Although a formalized yearly Annual
Giving Campaign did not begin at Jefferson for an additional 77 years,
Gross's challenge to the alumni of Jefferson Medical College immediately
bore fruit. In 1872, a committee of the Alumni Association
was appointed to secure funds to purchase a site on which to
build Jefferson's first definitive hospital. During a time when
a monetary panic was sweeping the country, this original
alumni fund raising effort totalled just over $350,000. Five
years later the hospital was ready for occupancy. It was one
of the first hospitals in America to be part of a medical
college for the teaching of clinical skills to medical students
at the bedside.
Following a few unsuccessful attempts at alumni fund raising
prior to 1948, Gross's sage advice finally was acted upon in
an organized fashion in 1948 with the launching of
Dr. Gibbon
Jefferson's first Alumni Annual Giving Campaign under the
chairmanship of Louis H. Clerf '12. Dr. Clerf is credited with envisioning a
class agent system that would provide ongoing communication with the
medical college through classmate/colleague direct mail solicitation. The
first Alumni Annual Giving Campaign in 1948 raised $108,313 for Jefferson
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from 3060 contributors. Much of the success of this initial Jefferson fund
raising effort was credited to the skill, imagination, hard work and personal
generosity of the class agents representing each class. During this initial fund
raising campaign the Alumni Association agreed that an award would be
presented to the class raising the largest amount of money, to the class with
the highest percent participation and to the class with the highest number of
contributors. The class agent system has proven to be a very successful
device and has remained the core strength of Jefferson's
Alumni Annual Giving effort.
Louis H. Clerf '12 served as Chairman of the Alumni Annual
Giving Program from 1948 to 1951. He was followed as
Chairman by Theodore R. Fetter '26 who served from 1952 to
1955. Next came John H. Gibbon Jr. '27 who served from 1956
to 1959. He was followed by Carroll R. Mullen '26 (1960-1961)
and Kenneth E. Fry '31 (1961-1964). J. Wallace Davis '42
became Chairman of the Alumni Annual Giving Campaign
Committee in 1965 and has led this effort since as the longest
serving Chairman. He has proven to be an innovative and
successful leader, instituting initiatives such as the President's
Club and other categories for giving such as the Nongraduate
Faculty and the Postgraduate Alumni. His efforts on behalf of Annual Giving
and the Alumni Association were recognized at the President's Club Dinner
in 1978 when he was presented with the Board of Trustees prestigious
Cornerstone Award. He received Jefferson Medical College's Alumni
Achievement Award in 1991.
Alumni Annual Giving surpassed $1,000,000 for the first time
during the 1983 Campaign. The total amount raised during the
recently completed 49th Campaign was an all-time high of
$1,761,935 from 4000 contributors. The goal for the 50th
Campaign is to surpass $2,000,000. From its inception in 1948
to the present, loyal Jeffersonians have contributed a grand
total of $31,235,758 for the medical college and its programs.
This magnificent expression of loyalty and support for the
medical college and its programs by the Alumni Association
was recognized by the Thomas Jefferson University Board of
Trustees who, at the President's Club dinner on October 3,
1997, presented their Cornerstone Award to the Alumni
Association of Jefferson Medical College. Over the years
Jefferson's Alumni Annual Giving Campaign has been recognized as one of
the finest institutional fund raising efforts in the country. The American
Alumni Council in 1962 awarded a trophy, together with a check for $1000
from the United States Steel Foundation, to Jefferson for placing first among
Professional Schools for outstanding sustained performance in
Annual Giving. Jefferson won the award again in 1965, and
again in 1970. Jefferson's Alumni Annual Giving record of
achievement also was a positive factor in helping the Alumni
Association win a national prize from the Association of
American Medical Colleges in 1995 during the 125th
Anniversary Celebration of the founding of the Alumni
Association of Jefferson Medical College. The AAMC's Award
for Excellence in Public Affairs was presented to Jefferson for
this multifaceted celebration of the history and the future of
Jefferson Medical College.
The President's Club, established in 1971, grants membership
to alumni and others who contribute gifts of $1,000 or more.
Benjamin Bacharach '56, Clinical Professor of Surgery, Vice-Chairman of the
Department and Associate Dean for Admissions has chaired the President's
Club Committee since 1977. In addition, he has chaired the Student
Financial Aid Drive since 1988 which, at this writing, totals $2,425,443.
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In the 49th Campaign, 587 members of the President's Club contributed
$1,132,253 or 64.2 percent of the total amount raised in that Campaign.
Other categories for giving established since 1948 are the Nongraduate
Faculty and the Postgraduate Alumni. In the 49th Campaign these two
groups combined to contribute $246,461. Although not a part of Alumni
Annual Giving, the University maintains a Development Office to work with
large contributors in developing charitable trusts, bequests for
buildings or endowed professorships. Under certain circumstances, alumni who give large gifts through the Development
Office may have their gifts credited to their class.
In his address to the fledgling Alumni Association in 1871,
Dr. Samuel Gross pointed out that "measures should be
adopted to endow scholarships and professorships." He
would be pleased to know his request has been answered in
abundance. In 1973 the Alumni Association established the
Alumni Professorship of Family Medicine with a pledge of
continuing support. Dale W. Garber '24 established the Ellen
M. and Dale W. Garber Professorship of Family Medicine in
Dr. Mullen
1984. Vernon Watson Pugh '53 established the Dr. Vernon
Watson Pugh and Frances Plimpton Pugh Professorship of Microbiology and
Immunology in 1985. Bernard W. Godwin Jr. '55 established the Bernard J.
Godwin Jr. Professorship in Prostate Cancer Research in 1989. Also in 1989,
Warren R. Lang '43 established the Warren R. Lang Professorship of
Pathology. Everett J. Gordon '37 established the Dr. Everett J. and Marian
Gordon Professorship in Orthopaedic Surgery in 1991, and in
1995 Paul A. Bowers '37 established the Paul A. and Eloise B.
Bowers Professorship of Obstetrics and Gynecology. Robert L.
Brent, M.D., Ph.D. and Lillian Brent established the Brent
Professorship of Pediatrics in 1996.
Friends of Jefferson Medical College have been equally
supportive. In 1910, Maria Gross Horwitz, daughter of
Samuel D. Gross of the Class of 1828, established the Samuel
D. Gross Professorship of Surgery. In 1946, Henry Reed
Hatfield, son of Nathan Lewis Hatfield of the Class of 1826,
established the Nathan Lewis Hatfield Professorship of
Urology. Beatrice Wilson, daughter of James C. Wilson of the Dr. Fry
Class of 1869, established the James C. Wilson Professorship
of Medicine in 1973. In 1992, Dorrance H.(Mrs. Samuel M. V.) Hamilton, a
term Trustee of the Board of Trustees of Thomas Jefferson University,
established the Dorrance H. Hamilton Professorship of Medicine, and the
Samuel M. V. Hamilton Family Professorship of Medicine. In addition,
alumni friendships with community leaders frequently result in unexpected
funding sources. An alumnus introduced his
friend, Sidney Kimmel, to Jefferson Medical College
a few years back. Sidney Kimmel, Chairman and
CEO of Jones Apparel Group, is very much involved
with philanthropy through the Sidney Kimmel
Foundation. In 1991, he donated funds to Jefferson
Medical College to establish the Kimmel Cancer
Center which now has achieved designation as a
Clinical Cancer Center by the National Cancer
Institute.

Committee. The class agent effort has been coordinated successfully for
many years by Joan E. Schott in the Alumni Office. Class agents send their
newly written class letters to Joan Schott who then has them individualized
by an outside secretarial service. They are returned then to each class agent
for personal signature and mailing. The class agent strategy stimulates class
loyalty and engenders friendly competition among and between the classes.
During the recently completed 49th Campaign, nine classes
reached or exceeded a class participation rate of 50 percent.
Mary Monteith, executive director of the Jefferson Medical
College Alumni Association, says "The class agents are the
real backbone of Annual Giving. Jefferson's continuing
success in Alumni Annual Giving largely is due to their
interest, their loyalty, and their hard work. Our class agent
system is the envy of many medical schools."
At the completion of the 49th Campaign, the Class of 1971
led by class agents James E. Barone and Terrence S. Carden Jr.
raised $48,237 to win the prize for the amount raised. The
Class of 1968, led by Lawrence V. Hofmann and Harold A.
Yocum, was second with $45,680, and the Class of 1969, led
by M. Dean Kinsey, took third with $42,030. The Class of 1978, led by class
agent Duncan Salmon, took top honors in the number of contributors
category with 103 classmates making a gift to Annual Giving. The Class of
1971, led by class agents James E. Barone and Terrence S. Carden Jr. took
second place with 89 contributors, followed by the Class of 1984, led by
class agent Guy M. Stofman, with 88 contributors. The Class
of 1947, celebrating its 50th reunion and led by class agent
Martin M. Mandel, checked in with an amazing participation
rate of 70 percent to win the top award in the participation
category. The Class of 1954, led by class agent John R.
Patterson, was second with a participation rate of 68 percent.
The 40th reunion Class of 1957, led by class agents Phillip.).
Marone and Bronson J. McNierney finished third with a
participation rate of 65.2 percent. Other frequent award
winners over the years have been the Class of 1946, led by
class agent James V. Mackell, and the Class of 1956, led by
class agent Eugene F. Bonacci. In addition, to celebrate its
35th reunion in 1991, the Class of 1956 donated a large
commemorative clock which is displayed now on the west
wall of Scott Plaza. The Nongraduate Faculty, led by Robert L. Brent, The
Distinguished Professor and the Louis and Bess Stein Professor Emeritus of
Pediatrics, contributed $163,312. The Postgraduate Alumni, led by Francis
X. Keeley, IM'60 and Lorraine C. King, REN'77, contributed $83,149.

Jefferson approaches the 50th Alumni Annual
Giving Campaign pleased with the growth of the
program since 1948, but not complacent about its
results. The Alumni Association approaches the 50th
Campaign with confidence built by a half century of
experience, and with the expectation that the two
million dollar goal will not only be reached, but also
that it will be surpassed. This confidence is bolstered
by the conviction that the alumni of Jefferson
Medical College believe strongly in the support of
private medical education. J. Wallace Davis '42,
Much of Jefferson's success in Alumni Annual Giving
present Chairman of the Annual Giving Fund
Drs. Bacharach and Davis
can be credited to how the effort has been
Committee, best expressed the belief of the Alumni
structured. From the beginning, each alumni class
Association about Jefferson Medical College alumni
has been solicited individually by a class agent, a classmate chosen specifiand Annual Giving when he wrote "I never cease to be impressed by the
cally for this role. Class agents write the multiple solicitation letters sent to
loyalty and generosity of Jefferson's alumni, faculty and friends." If Samuel
their classmates during each campaign, make telephone calls and otherwise
D. Gross, Class of 1828 and the first president of the Alumni Association of
encourage their classmates to contribute. These efforts are in addition to the Jefferson Medical College, could see what has resulted from his prxthetic
efforts made by the Chairman and members of the Annual Giving Fund
exhortation of 1871, it is certain he would be extremely gratified. M
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YEAR o ANNUAL GIVING
University Presents Cornerstone Award to the Alumni Association
r I 'he Alumni Association of Jefferson Medical
1 College was the recipient of the university's
Cornerstone Award at the President's Club
Dinner held in the landmark Crystal Tea Room
at the Wanamaker Building.
Jack Farber, Chairman of the Board of Trustees,
presented the Alumni Association with the
award for its "steadfast and enthusiastic"
support of Jefferson for a half-century. The
association, the largest group of living alumni of
any medical school in the nation, has donated
more than one million dollars to its alma mater
for 14 consecutive years, and more than
$31 million in total since its formation.
University President Paul C. Brucker, M.D. also
announced at the dinner that J. Wallace Davis
'42, the longtime Chairman of Annual Giving,
and his wife Gail have established a new trust to
benefit Jefferson Medical College. Dr. Brucker
said that the Davises' "outstanding generosity
and commitment to Jefferson continue to
astonish and encourage all of us."
Proudly holding the Cornerstone Award is Alumni President Joseph W.
Sokolowski Jr. '62, with Annual Giving Chairman J. Wallace Davis '42
and immediate past Alumni President Stanton N. Smullens '61

r

•
\4
ft.,11(-74 1I

;

4111

Dancing in the elegant
Crystal Tea Room
Raymond C. Grandon '45
and Dr. and Mrs. J. Woodrow
Savacool '38
Dr. and Mrs. Edward H. McGehee '45
on the dance floor
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Annual Giving Chairman Dr. Davis (center) with Alumni Presidents (back row) Vernick, Poole,
Funk, Sokolowski, Smullens, Bacharach, (front row) Gartland, Wagner, Baltzell, McGehee

Dr. and Mrs.
James I. Kelly '39
Mr. and Mrs. Joseph Field, Dr. and Mrs. Stanton N.
Smullens '61, and Stephen L. Schwartz, M.D.
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Mrs. Samuel M.V. Hamilton,
Chairman of the Jefferson 2000
Campaign, with John M. Levinson '53
and President Brucker

75" Year of Publication

Screening for Breast Cancer
Gerald D. Dodd '47
he past five years have been confusing ones for women and
physicians regarding recommendations for breast cancer
screening in the United States. In 1989, the American Cancer
Society (ACS), the National Cancer Institute (NCI), and 10
other national organizations had established consensus
guidelines on breast cancer screening. These included specific
recommendations for the screening of asymptomatic women:
mammography every one to two years for women ages 40 to 49,
and annually for those 50 and older. The American College of
Physicians, the American Academy of Family Practice, and the
U.S. Preventive Services Task Force declined to endorse the
guidelines, concluding that the available evidence was insufficient to support a recommendation for screening in the younger
group. Nevertheless, the consensus was widely accepted and it
seemed possible to proceed with the nationwide screening of
women over 40.
In late 1992, the preliminary results of the Canadian National
Breast Screening Study were leaked. These showed no benefit at
seven years of follow-up for the study groups who were offered
screening mammography. In fact, the 40- to 49-year-old
screened group had a higher mortality rate than the controls, a
finding which received extensive press coverage. Although this
amount was not statistically significant, both the NCI and the
ACS initiated a review of their guidelines.
In February 1993, separate meetings were held to analyze the
new and existing data, particularly with regard to women ages
40 to 49. Whereas the ACS concluded that there was insufficient
new data to change the consensus guidelines, the NCI's
International Workshop on Screening for Breast Cancer laid the
groundwork for the NCI's unilateral withdrawal of support in
September 1993. It is of interest that this action was taken
despite a National Cancer Advisory Board (NCAB) vote of 14 to
one against withdrawal.
Between 1993 and 1996, several updated results were presented
or published from the eight randomized controlled trials (RCTs)
that included women 40 to 49 years of age. These data
prompted both the NCI and the ACS to once again re-examine
the question of screening younger women. A consensus
conference was held in January 1997 under the auspices of the
NIH, but with guidance from the same individuals who had
Dr. Dodd, past national President of both the American Cancer
Society and the American College of Radiology, is the Singleton
Professor of Radiology at St. Luke's Episcopal Hospital,
Houston, and from 1966 to 1992 was Head of the Division of
Diagnostic Imaging at the University of Texas M. D. Anderson
Cancer Center. M. D. Anderson inaugurated an endowed chair
in his name, and in November presented a symposium on
"New Directions in GI and Breast Imaging" in his honor.
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organized the 1993 NCI international workshop. Again, after
two and one-half days of sometimes acrimonious debate, the
consensus panel reached a preliminary conclusion that the
newer information did not have sufficient impact to warrant a
recommendation for the screening of those 40 to 49 years of
age.
The ACS meeting followed in February and reached an opposite
conclusion. Not only did the ACS feel that screening of younger
women was appropriate, but due to information regarding
growth rates and sojourn time (time from when tumor is first
evident radiogically to time when clinically palpable) in this age
group, the ACS recommended that screening be carried out at
annual intervals beginning at age 40.
These conflicting positions added to the confusion that had
followed the 1993 international workshop and led to
Congressional hearings. The Director of the NCI stated that he
was "shocked" by
the panel's
Seemingly overlooked
statement and
referred the
in the academic dispute
question to the
is the fact that there are
NCAB for guidance
and advice. The
18 million women age
N CAB
40 to 49, 33,400 of
subsequently voted
17 to one in favor
whom will develop
of screening those
40 to 49 years of
breast cancer each year.
age, a recommenThe solution must not
dation which was
depend entirely upon
promptly accepted
by the NCI. In
inexact statistical
April 1997, the
methods.
NCI issued a
formal statement
advocating the examination of women in their forties at one- to
two-year intervals, a position which the ACS had abandoned in
February.
The consensus conference panel has refused to budge from its
position and its final report states that there is insufficient
evidence to warrant screening of younger women. It should be
noted, however, that not all of the panel were in agreement and
a minority report favoring screening of this group is also being
published. Dr. Suzanne Fletcher, Chairman of the NCI's 1993
International Workshop on Screening for Breast Cancer, has
publicly commented in reference to the conflicting positions
that major health care decisions are increasingly being made for
political reasons and that scientific evidence has become
secondary to other interests.
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Seemingly overlooked in this academic dispute is the fact that
there are 18 million women age 40 to 49, of whom 33,400 will
develop breast cancer each year. This is a significant problem
whose solution cannot depend entirely upon inexact statistical
methods and RCTs performed with outdated technology. A
pragmatic approach to all of the evidence for and against
screening is warranted.
RISKS AND COSTS
A number of risks have been attributed to mammography,
particularly with respect to the younger age group. These
include discomfort and possible trauma from compression of
the breast, and
increased falsepositive and
false-negative rates
in younger women
due to the
radiographic density of premenopausal breasts. But few tests
are performed without transient discomfort, and properly
performed mammography does not traumatize the breast.
Varying degrees of anxiety are experienced by most
individuals facing medical tests and their outcome; they are
not peculiar to mammography and certainly do not offer a
valid reason for not recommending the examination.

enced mammographers the difference is minimal and, with
those of average experience, between 75 and 80 percent of
cancers in young women will be detected.
In this regard, it should be noted that there has been a significant improvement in the training of technologists and
radiologists in the performance and interpretation of
mammograms. Formal examination in the subspecialty is now
required by the American Board of Radiology, and Congress has
mandated strict quality control via the Mammography Quality
Assurance Act of 1992.
Of greater concern are the costs resulting from false-positive or
indeterminant interpretations that require tissue biopsy to

A Continuing Dilemma

Considerations that are pertinent are radiation exposure and
costs of the examination.
Although there is no doubt that high doses of ionizing
radiation have a carcinogenic potential, at clinical diagnostic
levels this assumption is theoretical and obtained by extrapolation from higher values. Using the data developed by the
National Academy of Science on the biological effects of
ionizing radiation, 150 radiogenic carcinomas can theoretically be anticipated per one million women who undergo
annual screening mammography between the ages of 40 and
75 years. During the same period, 93,000 spontaneous cancers
will occur. This is a ratio of 650 to one. Since mammography
is capable of imaging the majority of breast cancers, including
those of radiogenic origin, the risk, when compared with the
potential benefits of early diagnosis, is minimal.
Assuming that annual mammographic screening is elected by
70 percent of women age 40 to 49 at the present Medicare
reimbursement rate of 55 dollars, the cost per annum comes
to approximately 700 million dollars. This will be increased to
a variable degree by supplemental diagnostic procedures.
Overall, mammography has a true-positive rate of 85 to 90
percent and, if confined to those in the 40- to 49-year age
group, sensitivity decreases slightly. However, with experi-
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exclude cancer. The costs of open biopsy are high (three to five
thousand dollars), but stereotactic core biopsies or ultrasonically guided fine-needle cytologic studies have the potential of
replacing the majority of open biopsies at approximately onethird the cost. Moreover, the bulk of initially questionable
studies are resolved by supplementary imaging techniques; the
rate of biopsy following mammography can be anticipated as
about one to two percent when the mammographers are experienced.
BENEFIT ESTIMATES
The major objection to the routine screening of women 40 to 49
years of age centers about the supposedly marginal evidence of
benefits derived from RCTs. Many factors enter into their design
and evaluation. The various types of bias are well known and
have been controlled to some extent in the screening studies.
However, with the exception of the Canadian National Breast
Screening Study (CNBSS), none of the trials has been specifically designed to detect the effectiveness of mammography in
women 40 to 49 years of age. In each the number of women in
this age group equalled one-third or less of the total study
cohort; the effect of screening on a particular age group was
determined by retrospective stratification.
Considerable variability also occurred in the equipment
employed, quality control procedures, the type and number of
mammographic projections, and the interpretive experience of
the radiologists.
And the follow-up periods on the study populations also
differed markedly, a factor of great importance in younger
women. The original Health Insurance Plan of New York
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screening trial showed no benefit to women 40 to 49 years of
age at the end of five years, but at eight years the survival rate of
the study group began to diverge from that of the controls. At
10 years a 23 percent decrease in mortality could be
demonstrated and this has remained relatively constant through
the ensuing 10 years.
Recognition of the limited statistical power in individual RCT,
especially among women ages 40 to 49 years, has led some
investigators to perform meta-analyses of the results of these
trials. Meta-analyses combine the results from different studies,
thereby increasing the total number of deaths and women-years
(the number of women times the number of years of follow-up)
in the collective study and control groups. Meta-analyses,
however, are not panaceas. They provide a mathematical
methodology for combining similar data (e.g., mortality data)
from different trials, but are blind to potential differences in
design, conduct, quality, and completeness of data among the
studies.
The evaluation of an individual RCT benefits from more
complete follow-up data that covers a longer duration, and the
same is true of a
meta-analysis. An
The Swedish trials,
analysis presented
considered as a group,
by Elwood et al. at
the 1993 internayield a 29 percent
tional workshop
mortality reduction.
found no significant benefit from
Inexplicably, these data
screening
were not included in the
mammography in
younger women,
preliminary statement
and was used as a
issued by the NCI's
reference point by
the NCI when it
consensus conference
withdrew its
panel in January 1997.
recommendation
for routine
screening for this group in 1993. However, only those data from
seven years of follow-up were used, despite the fact that
additional years were available.
The Canadian trial, although well-structured in many respects,
has been subjected to a number of criticisms. The relative merits
of these can be debated, but the most pertinent appears to be
the randomization process. Exactly what occurred is not clear,
but an excess of advanced cases was assigned to the study
group. Although this imbalance may be resolved with time, the
initial relative risk of 1.36 percent significantly affects the
results of a meta-analysis.
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Also worthy of note is the quality of mammography through at
least half the Canadian trial. This was judged substandard by
outside observers during the first two and one-half to three
years, and average during the last two years of the trial.
In 1995, Hendrick et al. performed a meta-analysis using more
current evidence. The analysis showed a 14 percent decrease in
mortality if the Canadian study was included. This number is
not statistically significant; however, if the CNBSS is excluded
there is a 24 percent decrease—a highly significant statistical
figure.
In 1997, a meta-analysis by the same investigators showed an 18
percent decrease in mortality when the Canadian study was
included. This number is statistically significant. The
incremental differences between 1993 and 1997 indicate the
importance of long-term follow-up when calculating benefits in
younger women.
The new data from two of the five Swedish trials, Gothenburg
and Malmo, demonstrated for the first time statistically significant benefits from individual trials for the subgroup of women
under age 50 at entry. The Gothenburg trial demonstrated a 44
percent mortality reduction among women 39 to 49, and the
Malmo trial a 36 percent reduction among women 45 to 49. All
five Swedish trials, when considered as a group, yield a 29
percent mortality reduction. All are statistically significant at the
95 and 99 percent confidence levels. Inexplicably, these data
were not included
of the preliminary
The recommendations
statement issued
by the American
by the NCI's
consensus
College of Physicians,
conference panel
the American Academy
in January 1997.

of Family Practice, and
Non-randomized
trials and clinical
the Preventive Services
series do not carry
Task Force will have a
the same weight as
randomized trials,
significant impact upon
but they do offer
acceptance of the
an indication of
the potential worth
guidelines.
of a procedure or
concept. Data
derived from the Breast Cancer Detection Demonstration Project
(BCDDP), which involved the largest group of women in any
study to date (283,322), indicated that the 20-year case distributions for the prognostic indicators most likely to be affected by
early detection, are the same for all age groups. These include in
situ neoplasms, invasive cancers without lymph node
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involvement, and lesions less than two cm in diameter (stages
zero and one). The overall death rates and adjusted survival
rates in these groups are essentially identical. Given the
established benefit of mammography among women over age
50, the similarity in survival and mortality pattern in all BCDDP
age groups provides indirect evidence of the potential benefit of
mammographic screening of women age 40 to 49.
The BCDDP data was presented at both the 1993 and 1997 NCINIH conferences. It was, however, essentially ignored in the
conclusions reached by the panels. Also overlooked was the
work of Tabar and his associates in Sweden who demonstrated
that there was no significant difference in survival rates between
the younger and older age groups provided that the diagnosis
was made before a given tumor had exceeded 10 to 15 mm in
diameter. These observations support the survival rates found in
the BCDDP and indicate that screening at more frequent
intervals may be necessary in younger women if maximum
benefit is to be achieved.
EFFECTIVENESS OF SCREENING
To be effective a screening procedure should, over an
appropriate period of time, show:
1) an absolute increase in the number of early cases .
2) an absolute
decrease in the
Only about half of
number of
advanced cases, and women follow the
3) an absolute
guidelines promulgated
decrease in
prior to 1997. The
mortality.
Indications that
outstanding factor
these criteria are
behind this is physician
being met by
mammography
recommendation.
screening may be
found in data
gathered by the American College of Surgeons National Cancer
Data Bank (NCDB) and in recent statistics compiled by the
Surveillance, Epidemiology, and End Results (SEER) Program of
the NCI.
Between 1972 and 1988 the number of in situ cases reported to
the NCDB rose from 1.9 to 12.9 percent. During the same
period, regional cancers dropped from 42 to 27.8 percent, and
patients with distant metastases decreased from 6.8 to 4.4
percent. Correspondingly, the number of patients treated by
partial mastectomy and radiation rose from three percent to 34
percent, and the use of radical mastectomy declined from 50.4
percent to two percent.
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Recent SEER figures shoW that the mortality rate of breast
cancer, which had remained essentially unchanged since 1950,
now shows a decline of 6.3 percent. This decrease is apparent in
all age groups, varying from 9.3 percent in women 50 to 59
years of age to 3.4 percent in those 70 to 79. Pertinent to this
discussion is an 8.1 percent decrease in women 40 to 49 years of
age. Undoubtedly adjuvant therapy played a part in this decline,
but it is probable that the major factor is the detection of earlier
stage disease due to the increasing use of mammography. A poll
conducted by the Jacobs Institute in 1993 indicated that 74
percent of women over 40 years of age have had at least one
mammogram during adulthood.
Given these results, it does not appear unwarranted to conclude
that the effectiveness of screening, including women in the 40
to 49 year age group, is now becoming apparent. It is also
probable that the delayed appearance of benefit in younger
women can be expected to result in a continuing decline in the
mortality rate. However, as noted, not all agree with these
conclusions.
As of this date, the American College of Physicians, the
American Academy of Family Practice, and the Preventive
Services Task Force have not changed their positions.
Obviously, their recommendations to their membership will
have a significant impact upon acceptance of the present
guidelines. Judging by Dr. Fletcher's recent statement,
continued opposition can be expected in other quarters and a
group of NCI staffers remain unconvinced that the statistics
support the recommendation to screen younger women.
In the face of these continuing disagreements, what should be
the stance of practicing physicians? The annual rate of 34,000
new cancers in women 40 to 49 is too large to be neglected. Be
that as it may, only about half of women in all age groups follow
the guidelines promulgated prior to 1997. The reasons for this
vary greatly, but the outstanding factor is physician recommendation. Many women are reluctant to initiate this practice on
their own; their doctor must recommend it at appropriate
intervals. There is also the matter of cost, and strenuous efforts
are being made to require insurance coverage for screening
procedures.
Although mammography is somewhat less effective in the dense
breasts of younger women, this is less of a barrier than generally
indicated in the lay press. There is no question that subclinical
cancers can be detected. One of only three screening techniques
capable of diagnosing cancers in the preclinical state, mammography has had a demonstrable effect on treatment patterns and
survival rates. Cost-benefit ratios notwithstanding, the human
element must be considered. It is prudent to screen all women
over 40 until a superior detection method becomes available. '13
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University Celebrates a Link to its Past: the McClellan House
ecent research by Dan
IN.-Flanagan, Archives
Technician, Thomas Jefferson
University, and Frederick B.
Wagner Jr. '41, The Grace
Revere Osler Professor
Emeritus of Surgery and
University Historian,
unearthed the fact that
Jefferson's founder, Dr. George
McClellan, lived at 912 Walnut
Street from 1832 until his
death in 1847. His son,
General George B. McClellan,
also lived there until 1842
when he left to attend West
Point. Elizabeth Brinton
McClellan, Dr. McClellan's
widow, sold the home in 1853,
but the McClellan-Jefferson
connection continued.
Between 1853 and 1913, two
McClellans graduated from
Jefferson, and the founder's
grandson filled the chair of
Applied and Topographical
Anatomy from 1905 to 1913.
The founder's brother, Dr.
Samuel McClellan
(1800-1854), was a faculty
member and served as Dean
from 1830 to 1834. Samuel's
father-in-law, Reverend Ezra
Stiles Ely, was a member of the
original Board of Trustees and
Jefferson's first major
benefactor.
No pertinent information can
be found about 912 Walnut
Street between 1853 and the
turn of the century. However,
the Alumni Bulletin of October
1956 pays tribute to a local
institution which loomed large
in the hearts of many Jefferson
students and faculty. The
article states, "Almost as much
a part of Jefferson as its laboratories and classrooms, is a
small barber shop at 912
Walnut Street, presided over
by J. Monroe Dean. Mr. Dean
has been friend and
confidante, as well as barber,
to many of Jefferson's 'greats,'
and has been serving Jefferson
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men since he began his
business in 1910."
Unfortunately, because the
connection between 912
Walnut Street and the
McClellan family was
unknown at the time, the
house at 912 Walnut Street was
demolished in 1974 to make
way for Barringer Residence
Hall.
The archival research proving
the connection between 912
Walnut Street and Jefferson
was sufficient to persuade the
Pennsylvania Historical and
Museum Commission to allow
the preparation of a curb site
marker to signify the
importance of the place. A
dedication and unveiling
ceremony, moderated by John
J. Gartland S'44, was held
October 14 in Connelly Hall
of the Bluemle Building. The
Reverend Edward C. Bradley,
Dr. Gartland, Dr. Wagner, and Mr. McClellan
S.J., M.D.'55 opened the
in front of the newly placed sign
program with an invocation.
The story behind the marker
912 Walnut Street: Last Residence
was told by Dan Flanagan and
Frederick B. Wagner '41, and
of George McClellan, M.D.,
the Pennsylvania Historical and
Founder of Jefferson Medical College
Museum Commission was
thanked for making the
Dan Flanagan, Archives Technician, Thomas Jefferson University
celebration possible.
The high point of the
ceremony was the attendance
of Mr. George Ely McClellan,
second great-grand-nephew of
Dr. George McClellan, and his
family who came from Lacey's
Spring, Alabama for the
ceremony. Mr. McClellan
presented the university with
two rare medical books that
came from the library of the
founder, Dr. George McClellan,
and were inscribed by him. The
attendees applauded as Mr.
McClellan unveiled the marker
which stands at 912 Walnut
Street as a perpetual reminder
of the bond between Dr.
George McClellan and
Jefferson Medical College.
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n December 1956 the Jefferson
Medical College Alumni Bulletin
paid tribute to a local institution
which loomed large in the hearts of
many students and faculty members:
Almost as much a part of Jefferson
as its laboratories and classrooms,
is a small barber shop at 912
Walnut Street, presided over by J.
Monroe Dean. Mr. Dean has been
friend and confidante, as well as
barber, to many of Jefferson's
"greats," and has been serving
Jefferson men since he began his
business in 1910.
The names of Dean's clientele form
a veritable who's who in the history
of Jefferson Medical College. John
Chalmers DaCosta '1885, John H.
Gibbon Jr. '27, and J. Woodrow
Savacool '38 are only a few of the
names on record as having
patronized this establishment.
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According to the article the
barbershop provided a sanctuary for
many overworked Jeffersonians:
In Mr. Dean's shop students have
poured out their troubles. Busy,
tired, and harassed doctors have
relaxed and, for a short time,
forgotten the pressures of duties.

Unbeknown to Mr. Dean and his
customers, Jefferson students and
faculty members were paying visits
to this building long before the shop
opened in 1910. By a strange coincidence, the barber shop was situated
in the basement of a house that once
belonged to Dr. George McClellan,
the founder of Jefferson Medical
College. Dr. McClellan purchased
the house in 1832 and occupied it
until his death, which occurred on
the premises in 1847.
Dr. McClellan inspired fierce loyalty
and devotion among the students,

75" Year of Publication

many of whom supplemented their
education by obtaining McClellan's
private instruction. McClellan
routinely carried out their training in
his home medical office. Though
McClellan often exhibited the characteristics of a stern taskmaster he
would, nevertheless, go out of his
way to make up for any injury done
to a student's feelings.
Washington Atlee '1829 provided a
glimpse of what this relationship was
like in an 1873 address before the
Alumni Association:
I matriculated in the fall of 1826,
and immediately entered the office
of Professor McClellan. He had a
large class of private students, and
was in the habit of quizzing them
every night on the lectures of the
preceding day. His manner was
earnest, his questions minute, and
he expected prompt and correct
answers. If he failed in getting such
a reply, he often became highly
indignant. On one occasion, while
examining on the anatomy of the
heart, a question went from one to
another unanswered, until it
reached the youngest member of
the class—a first course student.
McClellan could scarcely control
himself, and after exhibiting his
disappointment, he exclaimed: "I
lay my life . . . the youngest student
here will answer it!" The young
gentleman knew the question, but
having been placed in such an
invidious position, declined to
answer. The excitement increased:
"I insist upon it, you know it, and
you must answer." The reply was
quietly given. "There, now," said
McClellan, "are you not ashamed of
yourselves, gentlemen, some of you
second and third course students,
not to be able to answer a simple
question like that?" When that
young man left McClellan's office,
it was with the intention of never
returning to it again. Two weeks
passed by and he did not return,
although he was regular in
attendance on McClellan's lectures.
One Saturday, as he was entering
the lecture room, the Janitor placed
a note in his hand, which he at
once recognized as McClellan's
writing. It read thus: "Do you never
intend to show the light of your
countenance in my office again?
I shall be most happy to see you
there this evening." The student
kept his resolution, and did not go.
Next morning, soon after breakfast,
the servant summoned him from
his room, by announcing that a
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gentleman wished to see him in
the parlor. He went down, and
who was it but McClellan! "Come,
come," said he, "put on your hat
and coat; I want you to ride with
me this morning." The invitation
was gladly accepted, the thing
talked over, explanations were
made, and promises on both sides
given, and after dining together at
his own house, they parted
friends, and always remained so.
Soon after Dr. McClellan's death an
event took place which helped to

DeSilver's Philadelphia Directory and
Stranger's Guide for 1833 contains
the following listing: "McClellan,
Geo., M.D., Professor of Surgery,
248 Walnut St. abv. 9th."
Once it was known that the
McClellan residence stood above
Ninth Street, a visit to the
Philadelphia Historical Commission
led to the discovery of a document
which listed George McClellan as
the owner of a house in that
vicinity. This document, a brief of
title for 912 Walnut Street, indicated

The survey describes a three-story
dwelling with a rear extension. The
house featured up-to-date conveniences
on the second floor.
The description of the basement, where
the barber shop eventually opened,
deserves particular attention:
The basement story divided into
kitchen, dining rooms, short passage
. . . large pantry closet, kitchen, range
St boiler, stone sink with hot and
cold water and a dresser with doors
and drawers, one plain marble mantle
. . [and] a furnace in the kitchen
for warming the house which
appears safe.
During the 1960s and '70s, the
neighborhood around McClellan's old
home underwent a series of dramatic
transformations while many of today's
familiar landmarks were built, such as
Scott Library, Alumni Hall, the Gibbon
Building, and the Orlowitz and
Barringer Residence Halls. Needless to
say, the scale of this construction
activity made it necessary to demolish
dozens of buildings. Eventually,
McClellan's forgotten home became one
of the casualties. In 1974 the
Philadelphia Historical Commission
granted permission to the
Redevelopment Authority to tear down
the structure. The space was incorporated into a lot which was soon utilized
for the construction of the Barringer
Residence Hall. Today, one of Barringer
Hall's street-level shops, the Wawa food
market, has the distinction of being
located at 912 Walnut Street, and, as
they've been doing for over a century,
Jeffersonians are still constantly visiting
this site.

912 Walnut Street as it appeared ca. 1960.
Note the barber pole at lower left.
conceal the whereabouts of his last
residence. All of the published
accounts, in city directories, college
announcements, and obituary
notices, indicated that Dr.
McClellan's last address was at
248 Walnut Street. In 1850, or
thereabouts, the City of Philadelphia
introduced a new numbering system
which changed the street address of
McClellan's former residence to 912
Walnut Street. Fortunately for us,
one of the older city directories
provided a clue that linked both of
these numbers together.
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that Dr. McClellan purchased the
property on October 12, 1832 and
that his widow, Elizabeth Brinton
McClellan, sold it to a gentleman
named William Griffith in 1853.
The file also contained a copy of a
fire insurance survey, prepared for
Mr. Griffith, that had the old and
new street numbers written on it.
Moreover, this home inspection was
recorded only six months after
Elizabeth McClellan sold the
property. Presumably, the condition
of the house hadn't changed much
since her husband's death.
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The close proximity of 912 Walnut
Street to Wills Eye Hospital (its
immediate neighbor to the east) constitutes the last historical irony in this tale,
given the fact that George McClellan
established Philadelphia's first eye
hospital in 1821. McClellan's
"Institution for the Diseases of the Eye
and Ear" lasted for approximately four
years. It was superseded, in 1825, by the
creation of the Wills Eye Hospital,
which benefited from a Philadelphia
merchant's hundred thousand dollar
legacy. It has been speculated that
McClellan diverted his energies from his
fledgling eye clinic to the establishment
of Jefferson Medical College as a result
of his knowledge about the legacy, and
his realization that it would be
impossible to compete financially with
such a rival. Wills Eye Hospital
relocated to its present location from its
previous home at46th and Spring
Garden in 1980.11)
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APPOINTMENTS
Bolognese Appointed Chair
Mancall is Interim Chair
of Obstetrics and Gynecology of Neurology
often predict the onset
of premature labor.

arld J. Bolognese,

Rv .D. has been

EI4 llio tt Mancall, M.D. has
been named Interim
Chairman of Neurology. Dr.
Mancall has been a Professor
of Neurology at Jefferson
since 1995, and also taught
here from 1958 to 1965; he
was Chairman of Neurology at
Hahnemann University from
1976 to 1994.

appointed the Paul A.
Jefferson's department
and Eloise B. Bowers
boasts particular
Professor and
strength in maternalChairman of Obstetrics
fetal medicine,
and Gynecology. He
•
high-risk obstetrics,
comes to Jefferson
and gynecologic
after 26 years at Pennsylvania
oncology.
Hospital, the last 11 of them as
Chairman of Obstetrics and
One of Dr. Bolognese's primary
Gynecology.
goals will be to integrate the
services of the department of
Dr. Bolognese brings years of
obstetrics and gynecology
experience in general obstetrics
throughout the Jefferson
and gynecology and a
Health System. In addition, he
specialized interest in
plans to help build a research
maternal-fetal medicine. He has
division within the department
studied the identification and
re Department of
that will seek additional grant
treatment of premature labor
support for clinical research
Elleurology is expanding
and premature membrane
from national and international its state-of-the-art services
rupture, which account for well
sources. Ultimately, Dr.
with the establishment of a
over 50 percent of pregnancy
Bolognese hopes to develop a
Headache Center in addition
losses. He has also researched
center that will emphasize
to the new Comprehensive
the use of ultrasound to
women's and children's health
Epilepsy Center and the
identify cervical changes that
services throughout JHS.
Stroke Center.

Dr. Mancall has received
numerous awards for his
teaching ability, including the
1997 Baker Award from the
American Academy of
Neurology. He has published
on neurological complications
of chronic alcoholism,
malnutrition, and systemic
malignancy. it

Neurology Options Expand
with Headache Center, Stroke
Center, and Epilepsy Center

The Headache Center,
formerly located at
Germantown Hospital,
provides the latest in comprehensive care and research. Its
diagnosis and
Director is Stephen D.
management of the
Silberstein, M.D., and Cofactors that cause heart Director is William B. Young,
attack, stroke, and
M.D. Also on staff is Jeffrey
related conditions can M. Dayno, M.D., who is
produce stabilization
Associate Director of the
of the disease and
Jefferson Stroke Center. The
even reversal.
Stroke Center is directed by
Rodney D. Bell, M.D., and
Dr. Capuzzi's work has been
published in the New England
Journal of Medicine, Cell
Biology, the Journal of
Biological Chemistry, and the
Journal of Cell Biology. Dr.
Capuzzi earned his Ph.D. in
ndrew Freese, M.D.,
physiological chemistry from
h.D. has been appointed
Johns Hopkins, where he
Associate Professor of
completed his residency and
Neurosurgery and Director of
fellowship.

Capuzzi Directs Cardiovascular
Disease Prevention Center

D

avid M. Capuzzi,
M.D.'64, Ph.D.
has been appointed
Director of the newly
formed Cardiovascular
Disease Prevention
Center.
Dr. Capuzzi previously
served for a decade as Chief of
Endocrinology, Diabetes,
Metabolism, and Lipid
Disorders at Allegheny
University Hospitals. He
brings years of experience in
managing lipid disorders and
other risk factors that
accelerate cardiovascular
disease. He has helped
demonstrate that effective
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also includes neurointensivist David G. Brock, M.D.
The Comprehensive Epilepsy
Center, directed by Michael
R. Sperling, M.D., is one of
the largest epilepsy programs
in the world. It offers
complete outpatient care
using both standard and
investigational drugs, a full
array of diagnostic services
including video EEG
monitoring, an internationally renowned epilepsy
surgery program, genetic
counseling, specialty care
during pregnancy, neuropsychological evaluations,
psychological care, cognitive
rehabilitation, social support,
and community
education.

Freese Directs
Neurosurgery Research
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Neurosurgery Research. He
brings to Jefferson and Wills
Eye Hospitals added
experience in general and

of

Publication

functional neurosurgery,
including contemporary
surgical approaches to spine
disorders and brain tumors.
He will be performing
functional surgery for
epilepsy, Parkinson's disease
and other movement
disorders, and pain.
As director of neurosurgery
research at Jefferson, Dr.
Freese also supervises a large
research program, including
several initiatives for the
development of gene therapy
for Parkinson's disease,
epilepsy, cerebrovascular
disorders, and pituitary
tumors. He is co-founder
and Executive Director of
the Parkinson's Disease
Gene Therapy Consortium.
Dr. Freese has performed
basic studies on the
biochemistry of
Huntington's and
Alzheimer's diseases, and
developed new drug delivery
systems for neurological
disorders. He has
contributed to more than
100 scientific publications,
has edited several books and
journals, and has organized
international scientific
conferences on gene therapy
for neurological disorders.
Freese comes to Jefferson
and Wills Eye from the
University of Pennsylvania,
where he was a member of
the Institute for Human
Gene Therapy. He was also
Director of the Laboratory of
Molecular Neurosurgery at
Graduate Hospital. He
received his Ph.D. from the
Massachusetts Institute of
Technology, and did his
surgical and neurosurgical
training at the University of
Pennsylvania. 4
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AtlantiCare Health System Announces Exclusive
Partnership with Jefferson and duPont Hospital

A

tlantiCare Health System
nd Atlantic City
Medical Ccnter (ACMC) will
join forces with duPont
Hospital for Children, the
pediatric affiliate of Thomas
Jefferson University, to
collaborate on an exclusive
pediatric affiliation. This
agreement, once completed,
will be the first of its kind in
southeastern New Jersey and
is the initial step in the
development of a comprehensive regional children's
program.
The agreement will link
duPont's and Jefferson's
renowned clinical services,
specialty care, and teaching
programs with the
AtlantiCare Health System.
These services will be
available at ACMC and at the
new AtlantiCare Healthpark
in the English Creek section
of Egg Harbor Township.
The duPont Hospital for
Children is located in
Wilmington, Delaware.
Together, duPont and
Jefferson provide pediatric
care for close to 200,000
from across the country
annually.
The affiliation represents a
significant expansion of
duPont and Jefferson's
presence outside the
Philadelphia region and will
bring renowned pediatric
specialists from both duPont
and Jefferson to this region.
The duPont and Jefferson
doctors will collaborate with
local southeastern New
Jersey primary care pediatric
physicians in building a
world-class pediatric
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program for the residents of
southeastern New Jersey.

cardiology, neurology, and
gastroenterology.

According to AtlantiCare
President and CEO George
Lynn, the agreement is a
result of an extensive
planning process, which
included local physicians,
ACMC, duPont, and
Jefferson.

Long-term plans may include
duPont surgeons performing
surgery at the new
AtlantiCare Surgery Center in
AtlantiCare HealthPark.

"We are delighted that this
affiliation will bring the
expertise of not one, but two
outstanding partners to the
community that we serve,"
says Lynn. "Our goal at
AtlantiCare is to give area
children the very best
possible care. And together,
AlantiCare, duPont, and
Jefferson will make that a
reality by combining their
expertise with that of our
area's primary care pediatricians," added Lynn. "This
will complement our other
initiatives focusing on
children, such as Success
By 6® and AtlantiCare Kids."
The agreement calls for
duPont and Jefferson to
assist in the management and
operation of inpatient
pediatric units in both the
City and Mainland Divisions
of ACMC, including the
Neonatal Intensive Care Unit
at the City Division. They
will also support the
pediatric services provided in
ACMC's emergency departments and provide pediatric
subspecialties and pediatric
surgery at AtlantiCare
facilities. At these locations,
duPont and Jefferson will
assist AtlantiCare in coordinating specialty care for
children, including
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"Together we are building a
new model for the delivery of
world-class pediatric care,"
says ACMC President David
Tilton. "As we move forward,
we'll be evaluating the most
effective and efficient ways to
deliver that care, including
the appropriate access
points."
Commenting on the
duPont/Jefferson expansion
into southeastern New Jersey,
Paul C. Brucker, M.D.,
President, Thomas Jefferson
University, says, "We are
looking forward to bringing
our expertise to the shore
region, and we are especially
pleased that we will be able
to do so in partnership with
one of the region's leading
health tare providers."
AtlantiCare Health System is
an integrated network of
services with a vision of
improving health outcomes
and health status and
reducing costs for people
who live and work in
southeastern New Jersey.
AtlantiCare is composed
ofAtlantic City Medical
Center, AtlantiCare
Foundation, AtlantiCare
Health Plans, AtlantiCare
Behavioral Health,
AtlantiCare Health Services,
and InfoShare, an
information technology
company.
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ON CAMPUS
Women's Liaison Task Force
Begins Array of Activities
Women's Liaison Task
orce has formed at
Jefferson, and already has
several activities to foster
networking and address issues
pertinent to women in
medicine.

Dr. and Mrs. Rodgers beside the portrait, surrounded by family

Jefferson's Newest Painting
Honors Dr. Rodgers

Ar

trait of Joseph F.
Odgers '57, Associate
Dean for Residency and
Affiliated Hospital Programs,
was presented to the university
by his colleagues and friends.
Presiding at the presentation
was Dr. Rodgers's colleague in
the dean's office, James B.
Erdmann, Ph.D., Associate
Dean for Administration and
University Registrar.

Dr. Rodgers has spent most of
his career at Jefferson. A
specialist in infectious
diseases, he earned respect for
his diagnostic knowledge and
his empathy, and was elected
to a term as President of the
Volunteer Faculty Association.
He was appointed an Associate
Dean in 1984.
Joseph S. Gonnella, M.D.,
Dean and Senior Vice
President for Academic Affairs,
with whom Dr. Rodgers has
worked for many years,
accepted the portrait (painted
by Dean Paules) on behalf of
the faculty. With gentle
amusement Dr. Gonnella
recalled how, throughout his
career, Dr. Rodgers has
unhesitatingly stood up for
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what he believed in. "He tells
you what you should know,
not what you want to
believe."
Accepting the portrait for the
university, President Paul C.
Brucker, M.D. credited Dr.
Rodgers with filling an
important role behind the
scenes. "Getting hospitals and
hospital directors to work
together is difficult. Quietly
and efficiently, Joe Rodgers
gets things done."

Part of the spark to organize
the task force came from the
Association of American
Medical Colleges, which
established a nationwide
system of Women's Liaison
Officers appointed by deans of
medical schools. Jefferson's
officer is Karen D. Novielli
'87, a faculty member in
Family Medicine.
Dr. Novielli, in turn,
organized Jefferson's Women's
Liaison Task Force which
meets monthly. Each
department has appointed a
representative, and there is a
house staff representative and

a medical student represen.
tame.
To promote communication,
the task force distributes a
newsletter (for information,
contact Susan Parks, M.D. at
parksl@jeflin.tju.edu or via
voice mail 215 955 5266 ext.
91529).
In October the task force
hosted its first annual
reception. The speaker was
Loretta Finnegan, M.D., who
was a member of Jefferson's
faculty prior to her
appointment as Director of
the National Institutes of
Health's Women's Health
Initiative, a multicentered trial
enrolling 164,000 women. As
a way to promote networking
and socializing, many faculty
members sponsored a medical
student to attend the
reception as well. it

Biographical sketches of the
honoree were given by
Francis E. Rosato, M.D., The
Samuel D. Gross Professor
and Chairman of Surgery, and
Warren P. Goldburgh '52,
Honorary Clinical Professor of
Medicine, who was Dr.
Rodgers's practice partner
early in his career.
Dr. Rosato praised the
honoree for "injecting
trust—a terribly important
thing—into our relationships
with our affiliates," and for
defending the rights and
needs of the house staff. Dr.
Rodgers, he said, "has always
been there when Jefferson
needed him." it
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The 31st annual James L. A. Roth Visiting Professorship
was delivered by (at left) Albert J. Czaja Jr., M.D., Professor of
Medicine at the Mayo Clinic. Following his lecture, "Evolving
Concepts and Treatment of Autoimmune Hepatitis," Dr. Czaja
poses with (at center) James L. A. Roth, M.D., for whom the
visiting professorship is named. Dr. Roth is a past Chief of
Gastroenterology at Presbyterian Medical Center and Editor of
the fourth edition of Bockus's Gastroenterology. At right is
Anthony J. DiMarino Jr., M.D., the Rorer Professor of Medicine
and Director of Gastroenterology and Hepatology.
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This Magazine, One of the Oldest
of its Kind, Reaches its 75th Year

W

ith this issue, the
Jefferson Medical College
Alumni Bulletin has seen 75
years of continuous
publication under the same
name. It's always had the
same mission: news about the
college and about its alumni.

2

Following the 1997 Grandon Lecture, Dr. and Mrs. Raymond
C. Grandon '45 and University President Paul C. Brucker,
M.D. go to the podium to congratulate speaker Karen Ignagni,
President and CEO of the American Association of Health
Plans, who spoke on "The Future of Managed Care and
Academic Medicine."

Medical Media Services

The first annual
Jimmy Brent Concert
was held October 30 in
the Lillian and Robert
Brent Auditorium,
which was named in
1996 in honor of
Robert L. Brent,
M.D., Ph.D., the
Distinguished Professor
and longtime
Chairman of Pediatrics, and his wife Lillian.
The concert is a memorial to their son Jimmy. Held each
year, it brings talented young musicians from Philadelphia's
world-renowned Curtis Institute to perform at Jefferson. Thus
the concert brings a humanist outlook to the medical campus.
Among the works performed were ones written by Jimmy Brent,
an accomplished musician.
(Below) members of the Brent clan gather before the concert,
which was attended by numerous friends, colleagues, and
students of Dr. Brent.

One of Jefferson's strengths is
its exceptional stability, and
this has been reflected in the
magazine. Other medical
schools may have superb, bigbudget publications, but
almost none is as enduring as
ours. Even the Harvard
Medical Alumni Bulletin,
though it was founded in
1892, ceased at certain points
and has only been continuous
since 1927. The Bulletin of the
University of Maryland School
of Medicine does have a slight
edge on us, having started in
1916. Yale's medical alumni
publication began in the
forties, and those of the
University of Pennsylvania,
Dartmouth, and Johns
Hopkins are positively
youngsters.
In December 1922, when the
first issue of the Jefferson
Medical College Alumni

Bulletin came off the press, the
college occupied a structure
located where the Curtis
Building (itself historiclooking to modern eyes) now
stands. The hospital was
simply what we call "Old
Main"—even Thompson had
not been built. W. W. Keen
'1862, world-renowned
neurosurgeon, was still participating in consultations, and
J. Chalmers DaCosta '1885,
author of a surgery text used
at most medical schools, was a
Co-Chairman of Surgery. John
H. Gibbon Jr. '27, later to
become famous for the heartlung machine, was not even a
student yet.
Three-quartets of a century
later, Jefferson continues its
strong position, and the
Bulletin reflects this in print
and in an electronic version
on the World Wide Web
(http://jeffline.tju.edu/CWIS/
JMC/alumnilbulletin.html).
Complete sets of the Bulletin
are maintained by the
National Library of Medicine
in Washington as well as
Jefferson's Scott Library and
the Alumni Office.
—Malcolm Clendenin

The Class of 2001 at a Glance
/223 students matriculated this fall at Jefferson Medical College
(350 were accepted out of approximately 10,000 total applicants)
/90 are female, 133 are male
/12 are members of minorities
/They come from 27 different states and the Virgin Islands, and
attended 98 different colleges
/26 are in the DIMER (Delaware Institute of Medical Education and
Research) program for students from Delaware
/18 are in the six-year, accelerated B.S./M.D. program with Pennsylvania
State University
/10 are participating in the Physician Shortage Area Program which
funnels graduates to practice in underserved areas
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FACULTY AND STUDENTS EARN MAJOR
Patrick V. Acevedo '98 was
selected a National Medical
Fellow, an honor accorded 35
minority students displaying
the knowledge, skills, and
experience needed for a career
in academic medicine. He is
involved in intercellular
research on prostate cancer
under the guidance of faculty
mentor W. Edward Mercer,
Ph.D., Professor of Microbiology and Immunology.
Previously Patrick had been
awarded the Sandoz
Pharmaceuticals Prize for
Research in Immunology and
Oncology in 1992 and 1994.
Robert L. Brent, M.D., Ph.D.,
the Distinguished Professor of
Pediatrics, has been elected to
membership in the Institute of
Medicine of the National
Academy of Sciences. He was
given this honor on the basis
of his research achievement
and his involvement with
critical issues affecting the
public's health, in particular
the causes and prevention of
birth defects. Dr. Brent is
Jefferson's first pediatrician to
be elected to the academy.
Thomas Jefferson University
honored him in 1996 by
creating the Brent
Professorship which is held by
the Chairman of Pediatrics,
and by the naming of the
Lillian and Robert Brent
Auditorium.
Steven J. DiBiase, M.D.,
Resident in Radiation
Oncology, has been selected
as an American Society for
Therapeutic Radiology and
Oncology (ASTRO) Research
Fellow for 1997-98. Dr.
DiBiase is conducting basic
research with George Iliakis,
Ph.D., Professor of Radiation
Oncology, evaluating p53
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mutations and their effects
on cell radiosensitivity and
DNA repair.
Stephen A. Feig, M.D.,
Professor of Radiology, was
elected Vice President of the
Society of Breast Imaging at
its annual meeting in April
1997. The SBI membership
consists of 1,700 radiologists from the United States
and abroad who subspecialize in breast imaging.
Kelly Herbert, Class of
2000, was recently awarded
a $3,000 scholarship by the
Alpha Omega Alpha Honor
Medical Society for her
study of how chemotherapy
can sensitize cancer cells to
respond to lower levels of
radiation treatment so that
nearby healthy cells are less
affected. She was one of 40
AOA National Research
Award Scholarship winners
for 1997.
Ronald P. Jensh, Ph.D.,
Professor of Pathology,
Anatomy, and Cell Biology,
received the Bucknell
University Alumni Award
for outstanding
achievement in a
profession. Dr. Jensh's
research focuses on
preventing birth defects,
and applying innovative
technology to biomedical
education.
Evelyn J. Mackin, P.T.,
Director of the Hand
Rehabilitation Foundation,
was honored in San Diego
in September at the annual
meeting of the American
Society of Hand Therapists.
She is the founder and past
President of the American
Society of Hand Therapists,
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Founder and first President
of the International
Federation of Societies of
Hand Therapists, as well'as
the Founder and first
Editor-In-Chief of the
Journal of Hand Therapy
which has a worldwide
readership. With James M.
Hunter '53 and Anne D.
Callahan, 0.T., Mrs.
Mackin is coeditor of the
book Surgery and
Rehabilitation of the Hand. It
is in its fourth edition, and
is considered the bible of
hand rehabilitation. Mrs.
Mackin has been with the
Philadelphia Hand Center,
an affiliate of Jefferson, for
30 years. The annual hand
surgery symposium cosponsored by Thomas
Jefferson University, which
she also co-chairs, will have
its 23rd anniversary in
March 1998.

Clinical Outcomes, has
been named the 1997
individual Health Care
Hero by the Philadelphia
Business Journal for his
contributions regionally
and nationally toward
improving health care
quality and lowering costs.
Among other activities, Dr.
Nash serves as Associate
Director of Partnerships for
Quality Education, a
national Pew Charitable
Trusts program to bring
together academic medical
centers and managed care
organizations. He also
serves on the National
Performance Council of the
Joint Commission on
Accreditation of Healthcare
Organizations, and is Vice
Chairman of the American
Medical Association's
Physician Measurement
Advisory Committee.

S. Grant Mulholland,
M.D., The Nathan Lewis
Hatfield Professor and
Chairman of Urology, is the
recipient of the 1997
Alumni Achievement
Award from the Temple
University School of
Medicine. Dr. Muholland
has served on the editorial
boards of the Journal of
Investigative Urology
and Ostomy/Wound
Management. He has
published more than 120
articles in leading journals.
Dr. Mulholland is past
President of the MidAtlantic Section of the
American Urological
Association.

Mark K Ono R0'97,
Chief Resident in Radiation
Oncology this past year,
received a 1997 American
Radium Society Visiting
Oncologist Award. Dr. Ono
used the award to enhance
his Jefferson residency
education by participating
in a subspecialized elective
rotation at the University of
California, San Francisco.

David B. Nash, M.D.,
M.B.A., Associate Dean for
Health Policy and Director
of Health Policy and
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Charlene J. Williams,
Ph.D., Research Associate
Professor, Division of
Rheumatology, Department
of Medicine, has been
awarded a four-year grant
of $956,884 from the
National Institutes of
Health entitled "Molecular
Characterization of Familial
Chondrocalcinosis."
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kWA R D S
Dr. Carol Artlett Earns Awards for Scleroderma Research

A

re women who have been
derma and fetal cells found in
..pregnant more vulnerable
systemic sclerosis patients.
to certain autoimmune diseases
Recently, it was discovered that
such as scleroderma? For her
fetal cells which pass from the
study of this question, Carol
fetus to the mother can survive
Artlett, Ph.D., postdoctoral
in the maternal circulation for
fellow in rheumatology, has
many years after the birth of
received two grants and The
the child. Dr. Artlett identified
Pennsylvania State University's
the presence of fetal cells in the
Finkelstein Award.
affected skin of patients with
Along with J. Bruce Smith,
scleroderma and hypothesized
M.D., Professor of Medicine,
that these cells are inducing a
and Sergio A. Jimenez, M.D.,
response similar to GraftThe Dorrance H. Hamilton
Versus-Host Disease (GVHD)
Professor of Medicine, Dr.
in these patients. Her research
Artlett investigates the
team proposed to identify and
connection between sclerocharacterize the cells to gain a

better understanding of the
involvement that these fetal
cells have in scleroderma, and
to test the hypothesis that
GVHD induced by these fetal
cells may cause scleroderma in
some patients. This work could
possibly lead to novel
therapeutic methods to target
these foreign cells and
ultimately to cure the disease.
For this project, Dr. Artlett
received a postdoctoral
fellowship award from the
American College of
Rheumatology, and also was
one of nine investigators

nationwide to receive a scleroderma research grant funded
jointly by the Scleroderma
Federation and the United
Scleroderma Foundation.
The Finkelstein Award,
established in 1974 by The
Pennsylvania State University's
Hershey Medical Center,
recognizes a researcher in
training from among the
Commonwealth's six medical
schools for the most original
work in a scientific paper.
Additional criteria are clinical
importance, effort expended
and clarity of presentation. it

Botulism Vaccine Developed by Environmental Medicine Faculty

M

olecular biologists at
Jefferson have created an
oral vaccine against botulism.
The researchers believe that
such a vaccine could be used as
a prototype in developing
future vaccines for other
diseases such as diphtheria,
whooping cough and tetanus.
Eventually, they say, their
discovery may lead to a range
of oral vaccines that could be
inserted into common foods.

more practical solution is to
put the genes for the carriervaccines into a plant such as a
banana. As the banana grows,
it would automatically
synthesize the oral vaccines.
"The very properties that this
Whenever a person ate the
molecule possesses are the ones
banana, that person would also
The researchers have created a that would be essential for all
be consuming oral vaccines.
novel form of the toxin that
oral vaccines," he explains.
This might be a way to combat
retains the ability to survive the "The molecule could be used as
illnesses that are endemic to
GI system and enter the general a carrier to transport other
some parts of the developing
circulation, yet no longer can
potential vaccines from the
world."
poison nerves. As a result, the
gastrointestinal system into the
Lance Simpson, Ph.D.,
novel molecule is an effective
general circulation, where they Dr. Simpson and his colleagues
professor of medicine, Jefferson oral vaccine against botulism.
would evoke antibodies. If this are now constructing the genes
Medical College, and director
The scientists, reporting in
were to work, the novel carrier that will encode the carrierof the Jefferson Clinical Center November in the journal
vaccine molecules. They will
molecule could be the critical
for Occupational and
Infection and Immunity, detail
element needed to create a host test the ability of the molecules
Environmental Medicine, and
the results of experiments in
of new oral vaccines."
to act as oral vaccines in the
his colleagues, Nikita Kiyatkin, which they successfully
laboratory. If the work is
One use of this vaccine
Ph.D., and Andrew
immunized mice against
successful, the next step will
technology would be for
Maksymowych, Ph.D., used the botulism.
be to conduct human trials.
common diseases such as
sophisticated tools of molecular
One immediate use of a
diphtheria and tetanus. Dr.
Via Jefferson's Public Relations
biology to create a modified
office, this discovery gained
botulism vaccine, Dr. Simpson Simpson sees a possibility for
and non-toxic version of
notes, would be in veterinary
an even more intriguing use.
attention on the ScienceNOW
botulinum toxin, which is
medicine. Animals such as
Website of the American
nature's deadliest poison. The
"There are Third World
racehorses and farmyard
Association for the Advancetoxin, which is the cause of the
countries in which injectable or
chickens are susceptible to the
ment of Science, as well as
disease botulism, is ordinarily
even oral vaccines are still not
disease, making such a vaccine
WHYY-FM, the Philadelphia
encountered as a form of food
practical; the health systems
of interest to the pharmaceuaffiliate of National Public
poisoning. When someone
and finances are inadequate,"
tical industry.
Radio.
he explains. "What might be a
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ingests the toxin, it survives
the harsh conditions of the
gastrointestinal system and
moves into the general
circulation. It is eventually
delivered to the central nervous
system and causes paralysis.
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According to Dr. Simpson,
there may be far greater
applications of the work in
both veterinary and human
medicine.
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RESEA
Genetic Test. Identifies Uterine Novel Facility is Established
Tumors as Malignant or Benign for Cancer Vaccine Processing
searchers at Jefferson

Riave developed a new

genetic test that uses reverse
transcriptase-polymerase
chain reaction (RT-PCR) to
identify uterine tumors as
malignant or benign. The test,
which is more definitive than
the routine tests currently in
use, looks for the presence or
absence of the gamma-smooth
muscle isoactin gene. This
gene, whose absence
correlates positive with
malignancy, represents a
unique molecular marker of
uterine cancer. These findings
appear in the July issue of
Cancer.
The study, led by Kirk
McHugh, Ph.D., Associate
Professor of Pathology,
Anatomy, and Cell Biology,
and the person who first
identified the gamma-smooth
muscle isoactin gene, lends
new hope to women with
uterine fibroid tumors whose
diagnosis is inconclusive.
"Uterine fibroids account for
one-third of gynecologic
hospital admissions,"
explained Dr. McHugh. "Most
are diagnosed as benign
leiomyomas, but four to five
percent are malignant
leiomyosarcomas. Some other
tumors fall into a so-called
grey zone, with test results
proving inconclusive."
According to Dr. McHugh,
current tests cannot conclusively identify these grey zone
tumors, or "tumors of
uncertain malignant
potential," as benign or
malignant. "To err on the side
of caution, many times
women with tumors of this
type undergo hysterectomies
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to protect against the chance
that cancer is present. Our
test provides a definitive
answer that may spare these
women unnecessary surgery
and loss of their reproductive
organs.
RT-PCR is a highly sensitive,
diagnostic test that identifies
a tumor as benign if the
gamma-smooth isoactin gene
is present, and malignant if
the gene is not present.
"There is no grey zone with
this test," says McHugh. "It
gives a clear yes or no answer,
providing a definitive
diagnosis of cancer, lending
protection against potentially
unnecessary surgery and
follow-up radiation therapy as
well as providing peace of
mind for those women
diagnosed with benign
tumors."
The new genetic test is not
part of the standard battery of
pathologic tests
recommended for uterine
tumor tissue biopsies, but is
currently under experimental
use at Jefferson. The test acts
as a definitive second
opinion, especially important
for women of child-bearing
age who have been told that
they may have cancer and
should probably have a
hysterectomy. "Undergoing a
hysterectomy is an unsettling
experience for women of any
age, but can be especially
devastating for a young
woman who is hoping to bear
children," explains Dr.
McHugh. "For this small
population of women, a
definitive diagnosis of benign
versus malignant is
critical."
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efferson Medical College is
now home to a unique
cancer vaccine processing
facility. It is the only one of its
kind in Philadelphia, and
possibly the nation.
AVAX Technologies, Inc., of
Kansas City, Missouri—which
has exclusive rights to a
Jefferson-based vaccine
against malignant
melanoma—is building the
vaccine laboratory to increase
quantities of the vaccine for
future testing and use. The lab
is a so-called "clean lab,"
which means it meets strict
federal Food and Drug
Administration standards.
"If a company wants to
produce a vaccine to market,
the work must be done in an
approved facility. It's called a
Good Medical Practices lab,"
explains Professor of
Medicine David A. Berd '68,
who created the vaccine
technology. "It essentially will
be an industrial lab in an
academic facility."
Dr. Berd and his colleagues
are hoping that the $200,000
laboratory will help step up
the production of the
potentially life-saving cancer
vaccine.
The current vaccine is
autologous, meaning that it's
prepared from a patient's own
cancer cells. Each vaccine is
custom-made for the patient.
Before injecting the cells into
patients, the cells are inactivated and treated with a
chemical, dinitrophenyl,
which chemically modifies
them. The modified cells
apparently appear foreign
enough to the body's immune
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system for it to react against
them.
The vaccine treatment appears
to be effective in prolonging
the survival of patients with
malignant melanoma. In the
June 1997 issue of the Journal
of Clinical Oncology, Dr. Berd
reported the results of
treatments on patients with
melanoma spread to a single
lymph node site (stage III
disease). The vaccine
treatments were started after
the lymph nodes had been
removed. Of 62 patients, 36
were still alive after a median
follow-up time of 55 months.
The projected five-year
relapse-free and overall
survival rates for these
patients were 45 percent and
58 percent respectively. This
compares favorably with the
15- to 25-percent survival
rates reported in patients
treated with surgery alone.
Dr. Berd and his colleagues
will participate in a Phase III
trial to test the effectiveness of
the vaccine on patients with
disease that has spread to the
lymph nodes. The five-year
trial, already underway, will
compare the effectiveness of
an autologous melanoma
vaccine to the standard
treatment, which is alpha
interferon. The trial will
involve 250 patients seen at
institutions in several major
cities. If the trial is successful,
then AVAX will ask the FDA
for approval to allow it to
market the vaccine.
The new lab will not be
limited to vaccines for
melanoma. Dr. Berd currently
continues at right
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Breast Cancer Specialists, Meeting at Jefferson,
Agree on Means for Classifying Controversial Early Stage Cancer
In a very unusual move,
three medical journals are
concurrently publishing the
findings of 20 breast cancer
specialists from Jefferson and
around the world. They have
designed a system for classifying ductal carcinoma in situ
(DCIS), a controversial
malignancy found in the
breast, as a first step toward
improving patient treatment
for this type of early breast
cancer. DCIS currently
represents 20 to 25 percent of
all breast cancers diagnosed.
In a paper to be published
concurrently by Cancer,
Human Pathology, and The
Breast Journal, the international Consensus Conference
Committee outlines a classification system for DCIS that
takes into account how the
cancer's cells appear under the
microscope (nuclear grade),
the amount of necrosis, the
cells' arrangement
(polarization), and their

continued from left
is testing a similar vaccine for
ovarian cancer.
Berd explains that many labs
are working on generic cancer
vaccines, but few have
attempted autologous
vaccines because of the
technical difficulty involved in
producing a vaccine for each
individual patient. "We expect
to show that our autologous
cancer vaccine is not only
effective, but also practical
and applicable to large
numbers of patients at sites
throughout the country," he
says. #
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physical shape (architecture).
The consensus conference was
hosted by Jefferson and chaired
by Gordon Schwartz, M.D.,
M.B.A., Professor of Surgery.
"Now when DCIS is encountered in Timbuktu, it will be
classified the same way as in
Philadelphia or Washington or
London," says Dr. Schwartz.
The committee members
include pathologists, mammographers, surgeons, a radiation
oncologist, and a biostatistician, from Jefferson and
medical institutions around the
globe.

"If you can't define it, you can't
treat it properly," he said. "The
subtleties of classification are
such that the treatments may
be different based upon how
the subtleties of DCIS are
perceived. So we wanted to get
these experts to agree upon a
uniform system of classification."
The consensus of the
specialists was to identify a set
of factors in descending order
of importance:

✓How the cancer cells appear
on the miscroscope (nuclear
grade). The cells can have one
of three appearances: biologiThe report's significance in
cally aggressive; biologically
determining the recommended
non-aggressive; or a state
approach for DCIS is
between these two. The
confirmed by the fact that three
conference determined that the
journals have agreed to publish
more aggressive the cells are,
the paper at the same time. Dr.
the greater the chance of
Schwartz explains that "three
subsequent recurrence.
of the physicians participating
in the conference are also the
✓Amount of tissue death
editors-in-chief of the three
(necrosis): The conferees
journals. They thought it was
concluded that the more
cellular death found, the
important enough to reach all
greater the chance the cancer
three journal audiences."
might recur.
Although a majority of patients
with DCIS will not develop a
✓Cell formation (polarization):
more threatening cancer, in
The specialists determined that
cells that are well organized or
some patients, the DCIS can
progress to become an
in good formation are more
invasive, life-threatening
likely to be less threatening
malignancy. "Until now, the
than cells in a loose formation.
greatest challenge for
✓Physical shape (architecture).
physicians who treat DCIS has
Cell patterns were categorized
been to discriminate between
by the conference into five
the less aggressive and more
types:
aggressive cases," Schwartz
• Comedo (previously
says. As a result, the treatment
considered the type most likely
of DCIS has ranged from
to recur)
mastectomy to a combination
• Cribriform
of lumpectomy and radiation
• Papillary
treatment to lumpectomy
• Micropapillary
alone, depending on the
• Solid
physician's judgment.
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The conferees also concluded
that the size and distribution
of the DCIS should also be
taken into account in classifying the cancer. As part of
their report, the breast cancer
specialists recommended a
process for removing and
evaluating breast tissue for
DCIS, and recommended that
a radiologist, surgeon, and
pathologist work as a unified
team in this effort. The
conferees suggested that the
traditional surgical procedure
involving a needle-guided
localization be employed in
removal of the tissue sample.
It is also recommended that
metallic clips be placed on the
tissue specimen near the site
of the DCIS if the flakes
shown on the mammogram
are faint or within a very
small area of the specimen.
It was also recommended by
the conferees that biologic
markers such as estrogen and
proestrogen receptors or
nuclear proliferation antigen
Ki-67, for example, be
determined in each case,
although these markers are
not currently used to
determine treatment.
Dr. Schwartz notes that
Jefferson is in the forefront in
the use of these biologic
markers. Now that the
conference has determined a
means for better identifying
DCIS, the next step is to
determine a universally
acceptable clinical use for the
classification system, the
conference report states. The
conferees hope to meet again
in the near future to map out
that strategy.
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RESEARCH
Jefferson and SmithKline Beecham Link Clinical Research Efforts
homas Jefferson University
and SmithKline Beecham
(SKB) have entered into a
contractual relationship aimed
to enhance the future of
clinically based research.
"The positive implications of
Jefferson's agreement with
SmithKline Beecham are
many, and they are vast," says
Joseph S. Gonnella, M.D.,
Senior Vice President for
Academic Affairs and Dean.
"Not only is there an
immediate benefit of significant dollar amounts
committed to Jefferson
research efforts, but there are
huge potential long-term
benefits for both patients and
physicians," says Dean
Gonnella.
The university's goal of
expanding clinical trials
activity paralleled a newly
widened search by SKB for

leading medical centers to
partner with in an expanded
program of drug development.
"The SKB agreement marks a
major commitment by the
university to partnering with
industry for drug
development," says Gerald
Litwack, Ph.D., Associate
Dean for Scientific Affairs.
The new "SmithKline
Beecham Academic
Partnership," which this
leading pharmaceutical
company invited Jefferson to
join, currently involves 17
academic medical centers,
including Harvard, Duke,
Johns Hopkins, the University
of California, San Francisco,
Baylor, Washington
University, and the University
of Pennsylvania. The program
stresses development of
emerging new drugs in a wide
variety of areas. Clinical trials

must be of very high quality,
with time lines for completion
comparing one university
partner with the others to
achieve optimum trial results.
SKB will provide Jefferson with
from $250,000 to one million
dollars each year in clinical
research grants. In addition,
SKB will award an annual twoyear Faculty Research Grant to
stimulate interest by younger
physicians in clinical research.
The first $100,000 grant is to
David L. Fischman CD'91,
Associate Professor of Medicine
and Associate Director of the
Cardiac Catheterization
Laboratory (see article below).

Many investigators at
Jefferson already have a track
record of very successful
completion of clinical trials
with SKB and other
companies. The new SKB
program offers the
opportunity to broaden the
base of these investigators at
Jefferson.

In addition to SKB, Jefferson
has had a longstanding
relationship with Merck &
Co. Recently Rhone-Poulenc
Rorer made a similar major
commitment. These activities
are conducted through
Jefferson's new Clinical
Research Center directed by
The advent of the SKB program
Scott A. Waldman, M.D.,
neatly coincides with Jefferson's
Ph.D., The Samuel M. V.
goal of increasing clinical
Hamilton Family Professor,
research activity. This fiscal
and Robert L. Capizzi, M.D.,
year, our activity in clinical
The Magee Professor and
research is expected to increase
Chairman of Medicine.
by about five million dollars.

Stents are Better than Angioplasty When Treating
Reclosure of Vein Grafts after Coronary-Artery Bypass
Cardiologists at Jefferson
have found that treating
the common reclosure of vein
grafts in post-bypass patients
with stents instead of
angioplasty lowers the risk of
death, heart attack, and the
need for repeat bypass surgery
or angioplasty. These findings
may point to a new standard
of care for the hundreds of
thousands of patients who
undergo coronary-artery
bypass surgery each
year-501,000 such
procedures were performed in
the United States in 1994
alone—and later experience
complications associated with
the reclosure of the vein grafts
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used to construct the bypass.
The study appeared in the
September 11 New England
Journal of Medicine.
Coronary-artery bypass
surgery uses veins from the
leg to channel blood from the
aorta to branches of the
coronary arteries. increasing
blood flow beyond the
obstruction. "The physical
nature of a vein graft makes it
prone to reclosure. Within 10
years of surgery, nearly half of
all bypass grafts are
obstructed setting the stage
for recurrent angina or heart
attack," explains principal
investigator Michael P.
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Savage '80, Associate
Professor of Medicine .

grafts in our multicenter
study," says Dr. Savage.

Traditionally, balloon
angioplasty had been used as
an alternative to repeat
surgery to reopen the vein
grafts that clog with plaque.
The long-term outcome of
this procedure is poor,
resulting in high rates of
restenosis, heart attack and
death. Fifty percent of
patients treated with balloon
angioplasty reclose within six
months. "The poor long-term
outcomes of angioplasty in
these patients led us to
investigate the use of coronary
stents to reopen clogged vein

The trial consisted of 220
patients with obstructed
bypass vein grafts randomized
into two groups. One group
received angioplasty to
remove the obstruction, the
other received Palmaz-Schatz
stents. Six months after their
procedure, patients
underwent a follow-up
angiogram. "Our follow-up
demonstrated that the patients
who received stents had better
long-term clinical results,"
says Dr. Savage. "Stents had a
greater procedural success
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Two Missing Cancer-Suppressor Genes May Have Deadly Effects
ancer geneticists at
V./Jefferson, studying
specially bred "knockout"
mice, have found that two
genes that normally protect
against cancer may play a
greater role than previously
suspected in female
development.

by getting a better handle on
the mechanisms by which
these genes actually can affect
female development, scientists
may better understand the
genes' roles in both normal and
cancerous development,
leading to important new
therapeutic strategies.

absent or defective, the
thinking goes, the likelihood
of cancer development Would
be greater still.

P53 is the most common
known genetic defect in human
cancers. It may contribute to
the development of several
cancers, including breast,
colon, and lung. Normally, p53
In the September issue of
"The observation goes to the
Nature Genetics, Richard
heart of how tumors develop," is a kind of genetic guardian. If
Fishel, Ph.D., and postdoctoral he points out. "It was
genes become damaged, p53
fellows Aaron Cranston, Ph.D. previously found that this
shuts down everything until
and Tina Bocker, M.D. report
particular combination of
the damage can be fixed. MSH2
that female mice that lack a
altered genes is significantly
is a gene that helps cells' DNA
pair of tumor-suppressor
lower in human tumors—our
spell-check and repair itself
genes, p53 and MSH2, stop
results may suggest why that is during replication. In 1993,
growing and die a little more
the case. These are two of the
Fishel and colleague Richard
than a week after conception.
most commonly altered genes
Kolodner showed that when
in colorectal cancer, and
MSH2 is altered, it accounts for
Fishel, Professor of
understanding their
about half of all cases of genetiMicrobiology and Immunology
mechanism in carcinogenesis is cally linked hereditary
and co-discoverer of the
crucial to the development of
non-polyposis colorectal cancer
human MSH2 colon cancer
therapeutic strategies."
(HNPCC)—one of the most
gene, thinks the answer lies
common human cancer prediswith the X chromosome.
When one tumor suppressor
position syndromes (Fishel R et
Somehow, he theorizes, the
gene is missing, the subject
al., Cell, 74:1027, 1993).
missing genes throw off normal is much more likely than
cell proliferation and
Knockout mice lack a working
normal to develop cancer.
development. He believes that
When two such genes are
gene or genes and are used as
models to study the effects of
continued from left
cancer gene alterations, often
helping scientists understand
rate in opening blockages
"It is exciting to know that
cancer mechanisms and
without complications than in
stents can now offer better
develop effective therapies.
the angioplasty group. Also,
outcomes for patients whose
the diameter of the stented
long-term outlook was
The researchers found that
vessels six months postpreviously poor.
male knockout mice died from
procedure remained wider than
cancer at an average of 273
David L. Fischman CD'91,
those treated with angioplasty.
days—two to three times as
Associate Professor of
Finally, but most importantly,
quickly as they might die with
Medicine (see article on facing
the stented group experienced
only one missing gene. They
page), served as a co-investia 36 percent reduction in
expected that. But they didn't
gator on the study and
complications, including death,
expect to find that the
directed the core laboratory
heart attack, and repeat bypass
combination of missing genes
responsible for the
surgery and angioplasty."
was lethal to the female mouse
angiographic analysis. In
embryos. By day 9.5 of
Savage believes that the results addition to the principal
gestation the female mice
of the study, which led to the
investigators from Jefferson,
stopped developing and died.
December 1996 FDA approval
other centers collaborating on
of Palmaz-Schatz stents for the the study include the Johns
"The embryo was undergoing
treatment of coronary-artery
Hopkins Hospital, Yale-New
global apoptosis, or
bypass graft disease, points
Haven Hospital, and Beth
programmed cell death,"
toward a new standard of care. Israel Hospital, Boston.
he says. "These embryos are
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self-destructing. As many as 60
to 90 percent of the cells
underwent apoptosis."
During normal embryonic
development, certain genes of
one of the X chromosomes may
be turned off, a process called
X-inactivation. Normally, there
is some damage to the X and
other chromosomes when cells
duplicate and go through a "cell
cycle." Cells have an innate
repair mechanism to fix the
problem; both p53 and MSH2
are involved in regulating this
cycle as well as controlling the
genetic repair mechanism.
Without these two genes, the
result is global, catastrophic cell
death in developing females.
One mystery that remains is the
precise role of the two genes in
preventing such mass cell death
and allowing normal
development. The p53 gene has
been thought to have a critical
role in apoptosis.
Fishel sees several possibilities.
"The interesting observation is
that they are undergoing global
apoptosis independent of p53,"
he notes. "Many studies suggest
that cells that decide to
undergo apoptosis do it in a
p53-dependent pathway. That
presents two intriguing
questions: what is this p53independent pathway, and why
are the cells dying? The only
differences between males and
females is the extra X versus Y
chromosome. It might be that
one of the X chromosomes is
damaged beyond repair or that
the Y chromosome provides
protection," he said. "At the
moment we favor the 'excessive
X chromosome damage'
argument since both MSH2 and
p53 are involved in managing
DNA repair." it
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OBITUARIES
Marion W. Coleman '25 died March
7, 1996. A board certified urologist,
he served as Chief of Urology,
Oakland Naval Hospital during
World War 11. He practiced in
Dayton, OH and was on staff at
Miami Valley, Good Samaritan,
Kettering Memorial and Greene
Memorial Hospitals, Dayton, OH.
He was a Fellow of the American
Urological Association and the
American College of Surgeons. He is
survived by his wife, Maria, and a
stepson.
William T. Hunt Jr. '27 died August
24, 1997. A board certified ophthalmologist, he was on staff at Wills
Eye, Methodist and Thomas
Jefferson University Hospitals,
Philadelphia, PA. He served as a
Clinical Professor of Ophthalmology
at Jefferson. He was a Fellow of the
American Ophthalmologic
Association and the College of
Physicians of Philadelphia. He is
survived by two daughters.
James H. Wall '27 died June 13,
1997. A psychiatrist, he was on staff
at the New York Hospital,
Westchester Division, White Plains,
NY. A Clinical Professor of
Psychiatry at Cornell Medical
School, he was credited with
improving the diagnosis and
treatment of mental disorders and
alcoholism in Westchester County,
NY. From 1936-1946 he served as
Assistant Medical Director, New
York Hospital, Westchester
Division, White Plains,NY, and from
1946-1965 he served as its Medical
Director. At the time of his death he
resided in Freeport, ME. He is
survived by a son.
Robert E. McDade '29 died April 12,
1997. He was in family practice in
Juniata Park, PA. After retirement,
he moved to Pennsville, NJ. He is
survived by his wife, Lucille, and a
son.
Richard V. Hauver '31 died June 26,
1997. A board certified general
surgeon, he received the Legion of
Merit medal for service to wounded
soldiers during combat in World
War II. He practiced in Hagerstown,
MD where he was Chief of Surgery
at Washington County Hospital. He
was a member of Alpha Omega
Alpha Honor Medical Society and a
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Fellow of the American College of
Surgeons. He served as President of
the Washington County (MD)
Medical Society, 1945-46. He is
survived by his wife, Thelma, and
two daughters.
Nathan Heiligman '33 died August
4, 1997. He was a General
Practitioner with a special interest
in pulmonary diseases and practiced
in Allentown, PA. He was on staff at
Sacred Heart and Allentown General
Hospitals, Allentown, PA, and
Palmerton Hospital, Palmerton, PA.
He is survived by two daughters and
a son.
William N. Eames '35 died
December 31, 1996. He was in a
general medical practice in Trenton,
NJ. He held a staff appointment at
Mercer Hospital, Trenton, NJ. He is
survived by his wife, Grace.
Nathan Sussman '35 died February
25, 1996. A recognized authority on
care and rehabilitation of the
elderly, he was Chief of the Arthritis
Clinic and the Department of
Physical Medicine and
Rehabilitation, Harrisburg Hospital,
Harrisburg, PA, where he served
also as President of the Medical
Staff. He served as President of the
Pennsylvania Academy of Physical
Medicine and Rehabilitation, 196061. He is survived by his wife,
Hannah, a son and a daughter.
Oscar H. Cohen '36 died February
16, 1996. Board certified in
radiology and nuclear medicine, he
was a Fellow of the American
College of Nuclear Medicine, and a
past President of the Radiological
Society of New Jersey. He was Chief
of Radiology, All Souls Hospital,
Morristown, NJ, 1951-56, and Chief
of Radiology, Riverside Hospital,
Boonton, NJ, 1956-75. At the time
of his death he resided in Sun City,
AZ. He is survived by his wife,
Roslyn, two daughters and a son.
Morton W. Levenson '37 died June
8, 1997. After serving for eleven
years as a medical officer in the
Foreign Service of the Department
of State, he became a General
Practitioner in Lititz, PA. He was on
staff at St. Joseph's Hospital,
Lancaster, PA. He is survived by his
wife, Rhoda, a son and a daughter.
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Gerald Krosnick '38 died September
3, 1997. Board certified in obstetrics
and gynecology, he practiced in
New Haven, CT, and was on staff at
Yale-New Haven and St. Raphael's
Hospitals, New Haven, CT. A
member of Alpha Omega Alpha
Honor Medical Society, the Society
of Sigma Xi and a Fellow of the
American College of Obstetricians
and Gynecologists, he was a Clinical
Associate Professor of Obstetrics
and Gynecology at Yale Medical
School. He is survived by his wife,
Helen, and a daughter.
Victor P. Satinsky '38 died
September 7, 1997. He was a
Cardiovascular Surgeon on staff at
Allegheny University
Hospitals/Hahnemann, Philadelphia,
PA. An innovative surgeon, he
helped develop coronary bypass
surgery and other medical innovations, including instruments for use
in heart surgery. Later in his career,
he developed and directed
educational programs for young
people. A bachelor, he is survived
by a brother and two sisters.
J. Bainbridge Hanley '39 died
August 10, 1997. He was a Flight
Surgeon during World War II and
was awarded two Bronze Star
decorations. He practiced internal
medicine, with a special interest in
diabetes, in Bristol, CT. He held a
staff appointment at Bristol
Hospital, Bristol CT. He is survived
by his wife, Frances, three sons and
six daughters.
Lewis Lehrer '39 died August 15,
1997. Board certified in anesthesiology, he worked at Kensington,
Albert Einstein Medical Center and
Philadelphia General Hospitals,
Philadelphia, PA. From 1967-1980
he was Chief Anesthesiologist at
Underwood Memorial Hospital,
Woodbury NJ. He is survived by his
wife, Eleanor, two sons and
daughter Luisa, Jefferson '86.
James J. Quiney Jr. '39 died July 9,
1997. He was in general practice in
Bethlehem, PA. We have no further
information at press time.
Michael H. Lauria '40 died June 14,
1997. He was in general practice in
Ephrata, PA. He held staff appointments at Ephrata Community
Hospital, Ephrata PA, Lancaster
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General Hospital, Lancaster, PA and
Reading Medical Center and
St Joseph's Hospital, Reading PA. He
served as President of the Medical
Staff and member, Board of
Directors, Ephrata Community
Hospital, Ephrata, PA. His wife and
son predeceased him.
William J. Snape '40 died
September 21, 1997. Board certified
in gastroenterology, he practiced in
Camden, NJ and was on staff at
Cooper Medical Center, Camden,
NJ. From 1952-1980 he was Medical
Director of the Camden County
Psychiatric Hospital, Lakeland, NJ.
A frequent contributor to the
literature of his specialty, he was a
Section Editor for the fifth edition of
Bockus's Gastroenterology. He was a
Fellow of the American College of
Gastroenterology. At the time of his
death he resided in Palos Verdes,
CA. He is survived by a son.
Ander M. Mumford '41 died June
10, 1997. After 13 years in general
practice in Winterville, NC, he took
a residency in otorhinolaryngology
at Duke Medical Center, Durham,
NC. He practiced otorhinolaryngology in Greenville, NC from
1962-1982. He was on staff at Pitt
County Memorial Hospital,
Greenville, NC, where he served as
Chief of Staff, 1965-1966. He is
survived by his wife, Bedie, and a
daughter.
Frederick A. Robinson Jr. '41 died
September 30, 1997. He practiced
internal medicine in Lansdowne,
PA. He held staff appointments at
Delaware County Memorial
Hospital, Drexel Hill, PA, Bryn
Mawr Hospital, Bryn Mawr, PA, and
Philadelphia General and
Pennsylvania Hospitals,
Philadelphia, PA. He is survived by
two sons and a daughter.
J. Robert Fox '43 died August 7,
1997. Board certified in ophthalmology and otorhinolaryngology, he
practiced in Dover, DE. He was on
staff at Kent General Hospital,
Dover, DE and served on the
hospitals' Board of Directors. He was
a Fellow of the American Academy
of Ophthalmology and
Otorhinolaryngology, and the
American College of Surgeons. He is
survived by his wife, Jane, two sons
and a daughter.
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Mon Q. Kwong '45 died April 25,
1997. Board certified in
dermatology, he practiced in Los
Angeles, CA. He held a staff
appointment at Hollywood
Presbyterian Hospital, Los Angeles,
CA., and was a Fellow of the
American Academy of Dermatology.
He was an Instructor in
Dermatology at the University of
Southern California School of
Medicine, Los Angeles, CA. He is
survived by his wife, Henrietta, and
two daughters.
Allen H. Lee '46 died July 2, 1997.
He was in general practice in Selma,
NC. At the time of his death he was
Selma's sole practicing physician. He
is survived by his wife, Claudia, a
son and two daughters.
John IL Helff '47 died September

30, 1997. Board certified in
radiology and nuclear medicine, he
was Chairman of Radiology,
Middlesex General Hospital, New
Brunswick, NJ, 1952-69; Cheshire
Hospital, Keene, NH, 1969-81; and
Memorial Hospital, North Conway,
NH, 1981-94. He was a member of
Alpha Omega Alpha Honor Medical
Society and a Fellow of the
American College of Radiology. He
is survived by his wife, Barbara, two
sons and two daughters.

medical and corporate communities,
he was President of the College of
Physicians of Philadelphia 1990-92.
He is survived by his wife, Arlene,
two daughters and a son.
IL Phelps Potter Jr. '49 died July 17,
1997. Board certified in internal
medicine, he served as Acting
Chairman, Department of Medicine,
Medical College of Pennsylvania,
Philadelphia, PA, 1961-69. He then
moved to Paoli Memorial Hospital,
Paoli, PA where he served as Chair
of the Department of Medicine,
Chief of the Gastrointestinal
Section, and president of the
Medical Staff. He was a member of
Alpha Omega Alpha Honor Medical
Society and a Fellow of the
American College of Physicians. He
is survived by his wife, Beverly, and
two daughters.
Robert W. McLaughlin '51 died
March 20, 1997. He practiced
general medicine, obstetrics and
anesthesiology in Penn Yan, NY. He
was on staff at Soldiers and Sailors
Hospital, Penn Yan, NY. He was
twice President of the Geneva (NY)
County Medical Society. He is
survived by his wife, Joan, a
daughter and three sons. Son Scott
is Jefferson '95.
Robert B. Cahan '54 died July 29,

Charles S. Ryan '48 died October 4,
1997. He practiced occupational
medicine in Valley Forge, PA., and
was Director of Health and Safety
for the Sun Oil Company. He also
was Chairman of the Greater
Delaware Valley Health Care
Foundation and of the American
Petroleum Institute's Epidemiology
Research on Petrochemical
Workers. He is survived by his wife,
Laura, three sons and three
daughters.
Daniel L. ShawJr. '48 died August
16, 1997. He was a specialist in
clinical pharmacology and, after two
years in the Navy, began working at
Wyeth Laboratories, Radnor, PA.
On retirement in 1987, he was Vice
President of Medical Affairs at
Wyeth Laboratories. Highly
regarded both in the Philadelphia
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1997. Board certified in both
neurology and psychiatry, he
practiced general and forensic
psychiatry in San Francisco, CA. A
Fellow of the American Psychiatric
Association, he served as a Clinical
Associate Professor of Psychiatry,
University of California, San
Francisco. He is survived by his
wife, Bernice, and a son.
Carl W. Hassler '62 died June 19,

1997. He was in family practice in
Reading, PA. He held a staff
appointment at Reading Hospital
and Medical Center, Reading, PA. A
former star football player, he
served as team physician for the
football team of Wilson High
School, Reading PA. He is survived
by his wife, Elizabeth, and two
daughters.
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Jack W.P. Love Jr. '62 died October

25, 1997. Originally in general
practice in Woodbury, NJ, he later
switched to emergency medicine
and became board certified. He was
appointed Chief of Emergency
Medicine, Underwood Memorial
Hospital, Woodbury, NJ in 1974.
During his long and productive
tenure at Underwood Memorial
Hospital, he served as President of
the Medical Staff and a member of
the hospital's Board of Trustees. He
is survived by his wife, Sally, three
sons and two daughters. Son
Thomas is Jefferson 2000.
Laurence R. LeWinn '66 died July
17, 1997. Board certified in plastic
and reconstructive surgery, he
practiced in Palm Desert, CA. He
was Chief of Plastic Surgery at the
Eisenhower Medical Center, Rancho
Mirage, CA. He is survived by his
wife, Maja, a son and a daughter.
John P. Manges Jr. '68 died June 1,

1997. Board certified in internal
medicine, he served in the United
States Public Health Service on the
Wind River Reservation in
Wyoming, and as a member of the
Indian Health Service in Santa Fe,
NM. He then practiced general and
addiction medicine in St. Johnsbury,
VT. He held a staff appointment at
Northeastern Vermont Regional
Hospital, St. Johnsbury, VT. He
served for several years as President
of the Society for Re-Introduction of
Values into New England. In
February 1997, he relocated to
Boulder, CO to work as an internist
with Kaiser Permanente. He is
survived by his wife, Jeanne, and
two sons.
Donna Price '83 died April 21,
1997. Board certified in otolaryngology, she practiced in Syracuse,
NY. She was a Clinical Professor of
Otolaryngology, State University of
New York at Syracuse. She is
survived by her parents.
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K. Kalman Faber PD'49 died
October 20, 1997. Charismatic,
enthusiastic, and courageous,
"Kuddie" Faber became Jefferson's
first pediatric resident in 1947. In
the book Thomas Jefferson
University: Tradition and Heritage,
he is described as the doctor whose
growth virtually paralleled the
development of the Department of
Pediatrics into a modern pediatric
facility, and the man who was
elected by acclamation chairman of
the board of Doc Watson's Pub
across the street from the medical
college. He lived and practiced
pediatrics with gusto, and clearly
was Jefferson's most popular
pediatrician as evidenced by the
number of his colleagues' families,
students, nurses, and hospital
employees who became his patients.
He was a Clinical Associate
Professor of Pediatrics, and was in
private practice for 50 years. In
1993 Jefferson recognized his
lifetime contributions to pediatrics
and to Jefferson by awarding him
the Leon A. Peris Memorial Award,
given to a member of the volunteer
faculty for excellence in clinical
teaching and superior patient care.
He is survived by his wife, Elaine,
two sons, and two daughters.

Staff
Jack R. Schott died July 27 at age 59.
He was the husband of Joan E.
Schott, a 36-year employee in the
JMC Alumni Office (currently
Associate Director of Annual
Giving). Jack Schott was one of the
Philadelphia Flyers' earliest and
most loyal fans, and President of the
Flyers Fan Club from 1985 to 1992.
He was a dispatcher for Core
Trucking Company in Bensalem.
Our thoughts are with Joan and
their son Kenneth.
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CLASS NOTES
'27
Samuel M. Dodek of Chevy Chase,
MD was presented with a Certificate
of Recognition in appreciation of his
dedication and service to the
Department of Obstetrics and
Gynecology by the George
Washington University School of
Medicine, where he serves as an
Emeritus Professor.
'41
Louis C. Blaum Sr. of Bear Creek
Township, PA has retired from
medicine and he and his wife,
Kathleen, reside in Florida. Their
son Louis C. Blaum Jr. '72 of
Kingston Township, PA specializes
in thoracic and breast surgery. He is
on staff at Wyoming Valley
Hospital. The third generation is
Louis "Louie" C. Blaum III '97 of
New Brunswick, NJ who plans to
practice plastic and reconstructive
surgery. All three were members of
the same fraternity. They lived in
the same room at Alpha Sigma,
which became famous as "The
Blaum Room." The Blaums all agree
with Dr. Blaum Jr. who says, "There
is nothing better than to have been
given the privilege to be a part of a
patient's life and to make their life
better."

Co-authors of Thomas Jefferson
University: Legend and Lore,
Frederick B. WagnerJr. '41, The
Grace Revere Osler Professor
Emeritus of Surgery and University
Historian, and J. Woodrow Savacool
'38, Honorary Clinical Associate
Professor of Medicine, received
praise in the January 15, 1997
Journal of the American Medical
Association. Dr. Howard Spiro of
Yale University School of Medicine
applauded the editors' efforts "in
finding old pictures and other
details that embellish every article"
and encouraged anyone "curious
about the ways of doctors" to read
the book. It's available through the
Jefferson Bookstore, (215) 955
7922.
Herbert A. Luscombe, who from
1959 to 1986 chaired the
Dermatology Department, has now
fully retired from practice.
'45

tudents will be contacting alumni during November,
December, and January requesting housing while they are
interviewing for residencies. Alumni have found that this is a
fun way to catch up on what's happening at Jeff, and to meet
physicians-to-be who may soon be practicing in their region.
If you would be willing to host a student interviewing in your
area, please return the form below to JMC Alumni Office,
1020 Locust Street M-41, Philadelphia, PA 19107.

S

Class Year or Jeff Affiliation

Mailing Address

City

State

Zip

Daytime Phone
I would be willing to host a student interviewing in my area.
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David G. Simms of Huntington
Beach, CA was made an honorary
member of the German Association
for Orthopaedic Sports Injury after he
gave an invited presentation on
"Advances in Our Understanding of
Myofascial Trigger Points" in June
1997.
'47
Gerald D. Dodd of Houston, TX has
been awarded the Mucio Athayde
Cancer Prize by the International
Union Against Cancer for his contributions to breast cancer diagnosis
(see his article in this issue). Dr.
Dodd was among those who
developed modern-day mammography for the diagnosis of breast
cancer in women. He was presented
the award at the organization's first
Cancer Management Meeting in
Vienna.
'52

Stephen F. Balshi of Bethlehem, PA
is still working part-time as an
otolaryngologist, as well as traveling
extensively.

Can You Host a Student
Interviewing in Your Area?

Name

'46
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Herbert C. Mansmann Jr. '51,
Professor of Pediatrics, is
inducted into the Honor Roll
of the Philadelphia Pediatric
Society, upon the occasion of
the society's 100th anniversary.
Here he receives his award
from Gary A. Emmett '76,
Director of General Pediatrics
at Jefferson, who was
Treasurer of the society.

John M. McGehee of Mobile, AL was
recognized for his service to internal
medicine and awarded the Alabama
Chapter Laureate Award presented by
the American College of Physicians.
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'58 40th Reunion June 6
Since retiring, James M. LaBraico of
Charlestown, RI, has been doing
consulting work to the pharmaceutical industry. He is an active
volunteer at the Boston Museum of
Science and recently elected to the
Board of Directors of its Volunteer
Service League.
'59
Herbert J. Somers and his favorite
working partner, his daughter Debra
Lynne Somers '89, are both
obstetrician/gynecologists. The
Somers father-and-daughter team,
along with two other physicians in
the practice, work out of three
offices. They are part of the Temple
Physician Network, which is affiliated
with Temple University Hospital.
'60
Charles W. Balaicuis of Johnson
City, TN recently opened his office in
Elizabethton, TN for the practice of
Child Psychiatry and Habit
Disorders. He had a daily worldwide
radio program for 10 years.
'61
Jack Krauss of Merion Station, PA
has been appointed Instructor of
Psychiatry and Human Behavior at
Jefferson.
>64
James J. Houser of Franklin, PA was
honored by the Pennsylvania Chapter
of the American College of Physicians
with the prestigious Laureate Award
for his "abiding commitment to
excellence."
'70
Harvey B. Lefton of Huntingdon
Valley, PA is President-Elect of the
Frankford Hospital Medical Staff and
Head of the Section of
Gastroenterology.
Norman G. Loberant of Nahariyn,
Israel, Director of the Radiology
Department at Western Galilee
Hospital in Nahariyn, spoke on his
study of the ductus venosus in
premature infants at the 1997
Meeting of the Israel Ultrasound
Society. Special guest speaker at this
meeting was Laurence Needleman
R'83, Associate Professor of
Radiology at Jefferson. Dr.
Needleman delivered the 15th
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Goldstein Appointed Vice President for
Research at Juvenile Diabetes Foundation
Diabetes Interdisciplinary
Research Programs
throughout the world.

R

obert A. Goldstein,
M.D.'66, Ph.D.,
M.B.A. has been
appointed Vice President
for Research of the
Juvenile Diabetes
Foundation International
(JDFI). Dr. Goldstein will
work out of both New
York City and Washington, D.C.
and will be responsible for the
world's largest private, nonprofit
program in diabetes research. In
addition, a major responsibility over
the next months will be to continue
the work of JDFI's Research Task
Force (which Dr. Goldstein has
been co-chairing) and to develop
the Task Force's final reports and
the plans and programs to
implement its recommendations.
In a typical year JDFI provides over
$30 million to basic and clinical
research for a cure for diabetes and
the ability to prevent the disease and
its complications. A wide variety of
research programs are being
supported through funds provided
by the donations of individuals,
foundations, and corporations.
These include hundreds of investigator-initiated research grants,
career development awards, and
postdoctoral fellowships and 26

Annual Barry B. Goldberg Lecture
(named for a Jefferson faculty
member) along with additional talks
on various topics in Doppler
sonography. Dr. Loberant's daughter
Leslie will graduate from Jefferson
Medical College this June.
'74
James D. Plumb of Doylestown, PA,
who is a Clinical Associate Professor

Dr. Goldstein is a
physician, clinicianinvestigator, basic
scientist, and research
administrator with
several years of
experience as a senior administrator
at the National Institutes of Health.
Dr. Goldstein completed his
internship in internal medicine at
Philadelphia General Hospital, and a
residency in internal medicine and
fellowship in pulmonary disease at
the Veterans Administration
Medical Center in Washington, D.C.
He earned a Ph.D. in
microbiology/immunology at
George Washington University, and
subsequently served as Acting
Director of the Pulmonary Disease
Division of George Washington
University Medical Center.
In 1978, Dr. Goldstein joined the
National Institute of Allergy and
Infectious Disease (NIAID) and
served successively for a decade as
Chief of Allergy and Clinical
Immunology and then Chief of
Clinical Immunology and
Immunopathology.

of Family Medicine and Associate
Medical Director of the Jefferson
Hospice, was awarded the
Pennsylvania Bar Association's
Liberty Bell Award. It is given
annually to a Pennsylvanian who is
neither a lawyer nor a judge and has
demonstrated a commitment to
community service. Dr. Plumb
received the award for his efforts as
the faculty advisor for JeffHOPE, the
student-run, four-site medical clinic

Read the Bulletin on the Net
This magazine is available on-line at
http://jeffline.tju.edu/CWIS/JMC/alumni/bulletin.html

The electronic version includes all the photos and graphics
as well as text. Back issues are there too. Explore the options
within the Reader available on the World Wide Web site—
including zoomable photos and topic-search capability.

Medical College Alumni Bulletin

December 1997

75th Year

In 1988, Dr. Goldstein became
Director of the Division of Allergy,
Immunology, and Transplantation,
one of the three extramural
divisions of the NIAID. His responsibilities in this position included
management of a research portfolio
of over 1000 grants, contracts, and
fellowships amounting to approximately $216 million in fiscal year
1997. In addition, he was responsible for relating NIAID not only to
other NIH institutes, but also to
other governmental agencies such
as the Veterans Administration and
the Food and Drug Administration,
to the pharmaceutical and biotechnology industries, and to a variety
of private nonprofit constituencybased volunteer organizations. He
has also been serving as Director
of the World Health Organization's
Collaborating Centre for Allergic
Diseases at NIAID.
In 1992, Dr. Goldstein received a
M.B.A. degree from New York
University's Stern School of
Business.
Dr. Goldstein has published
numerous journal articles relating
to cell-mediated immunity and
pulmonary diseases and has served
as a reviewer for the Annals of
Internal Medicine and the New
England Journal of Medicine.
for homeless and underserved
Philadelphians.
'75
Irwin S. Goldstein of Bala Cynwyd,
PA has been appointed an Instructor
of Dermatology and Cutaneous
Biology at Jefferson.
Janine A. Matsho of Philadelphia
was recently promoted to Attending
Surgeon on the Cataract and
Primary Care Services at Wills Eye
Hospital. She serves as President of
the Ophthalmologic Club of
Philadelphia.
'76
Kurtis D. Jens of Lancaster, PA and
David E. Nutter '76 have recently
formed Mid-Atlantic Psychiatric
Physicians in Lancaster. Dr. Jens has
been installed as President of the
Lancaster City and County Medical
Society.
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Play Your
JEFFERSON-BLUE Chips
Right

Do you own stock in any of these companies?
Disney
Abbott Labs
Gillette
American Int'l Group
Hewlett-Packard
Archer-Daniels-Midland
Intel
Boeing Co.
IBM
Campbell Soup
Johnson
& Johnson
Coca-Cola
Compaq
Lucent Technologies

McDonald's' Corp.
Microsoft
Motorola
Oracle
Procter & Gamble
Sherwin-Williams
or other appreciated stocks

If so, you can increase your income by making a gift of your appreciated shares to a Jefferson Life Income Fund.
Historically, these (and many other stocks) have been excellent long-term investments. However, they all currently pay
less than two percent annually. By making a gift of appreciated stocks to Jefferson, rather than selling them, you can achieve:
/Diversification of your portfolio
/A significant increase in your income
/Free gift management by Jefferson
/An immediate income tax deduction
/The satisfaction of investing in Jefferson's future
/Freedom from capital gains liability
For more information on Jefferson's life income arrangements, please contact
Frederick "Fritz" Ruccius
Director of Development for Planned Giving
834 Chestnut Street, Suite 314
Philadelphia, PA 19107-5127
215-955-7990 Fax 215-923-5164
email: frederick.ruccius@mail.tju.edu

'78 20th Reunion June 6
Rudolph M. Krafft of Cortland, OH
is the new Associate Director of the
Family Practice Residency Program
at St. Elizabeth Health Center in
Youngstown, OH.
Paul E. Pilgram of Salt Lake City,
UT and wife, Christine joyfully
announce the birth of triplets. The
two boys and one girl were born
December 13, 1996 and are finally
home after their five-month stay in
the hospital. The triplets are doing
extremely well.

dinner with Marianne T. Ritchie '80
and her husband, Stuart L. Gordon
'81, and James A. Wilson '80 in
New Jersey.
Joseph M. Devlin and his wife,
Anita, of York, PA proudly
announce the birth of Madelyn
Regina, born June 3, 1997.
John A. Friedline of Royal Oaks, MI
has switched specialties from family
medicine to pathology, having just
completed his residency in anatomic

and clinical pathology at West
Virginia University. Dr. Friedline
has started his fellowship in
hematopathology at the William
Beaumont Hospital in Royal
Oaks, MI.
'83 15th Reunion June 6
Louis F. D'Amelio of Belle Mead, NJ
was recently promoted to Associate
Professor, Section of Trauma and
Surgical Critical Care, UMDNJRobert Wood Johnson Medical

David H. Trump of Clifton, VA, a
Captain in the U.S. Navy, is
currently Director, Military Public
Health in the Office of the Assistant
Secretary of Defense for Health
Affairs.

The Alumni at a Glance

'80

/Total number of postgraduate alumni living and deceased:
3,090

Donna P. Carr of Leucadia, CA has
retired from her private practice of
internal medicine due to pulmonary
and orthopaedic problems. She is
presently at home caring for her
eight-year-old daughter and fiveyear-old son. She and her husband,
Ken, recently visited Gary Dukart
'80 in California, and had a family
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School in New Brunswick. A good
friend and classmate of his, John P.
Sutyak '83, is a member of the same
department as Louis; they have both
achieved this milestone at the same
time. Dr. D'Amelio states, "Many of
our best residents are Jeff
graduates."
Timothy M. Heilmann and wife,
Sue, of Williamsport, PA welcomed
their seventh child, Jennifer, in
April of 1997. Dr. Heilmann is
currently an Associate Director of
the Williamsport Hospital Family
Practice Residency Program.
'88 10th Reunion June 6

/Total number of graduates living and deceased since the
founding of Jefferson Medical College: 27,405
/Number of living alumni: 9,731

Scott E. Olitsky of Buffalo, NY have
been named Program Director of the
Residency Program in
Ophthalmology at The State
University of New York at Buffalo
where he is Assistant Professor in
the division of Pediatric
Ophthalmology.

/Total number of living postgraduate alumni: 3,008
/Total number of Jefferson Medical College graduates
who did part or all of their training at Jefferson: 1,397
/Total number of living Jefferson Medical College graduates
who did part or all of their training at Jefferson: 1,347
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'89
Herbert C. Conaway Jr. of
Burlington, NJ served as a Captain
in the Air Force medical corps
from 1992 to 1996. He also earned

75'h Year of Publication

YOUNG INVESTIGATOR
Brezinski Develops Noninvasive Method to
Detect Early Signs of Cancer and Heart Attacks
esearchers at Massachusetts
eneral Hospital led by
Mark E. Brezinski '88, in
conjunction with scientists at
the Massachusetts Institute of
Technology, have developed a
noninvasive method of
detecting early signs of cancer
and heart attacks, which they
reported in Science magazine,
June 27, 1997.
The new method is known as
optical coherence tomography
(OCT). OCT produces a clear
picture of a cross-section of
bodily tissue without requiring
surgical biopsy. Using laser
light, OCT can magnify tissue
to allow visualization of
individual cells without
damaging the tissue.

microscopic early signs of
disruption in tissue terrain can
be detected and treated.
The infrared light used in OCT
is introduced to tissue by
means of a small catheter, or
endoscope, which can be used
virtually anywhere in the body.
Dr. Brezinski, one of the two
principal investigators, is a
cardiologist at Massachusetts
General Hospital, an Assistant
Professor at Harvard Medical

says Professor Fujimoto. To
date, several thousand patients
have been examined using
OCT. The results suggest OCT
may be a promising way to
diagnose early-stage glaucoma.
In 1994, in a collaboration led
by Professor Fujimoto and Dr.
Brezinski, OCT imaging was
developed for optical biopsy in
nontransparent tissue which
represents most of the tissue
of the body.

OCT is based on optical fiber
technology, the same
technology now used in
telecommunications. An optical
fiber is a string-like component
which guides light waves,
allowing a light beam to be
controlled over long distances
and around bends.
OCT can be compared to
ultrasound, except that infrared
light waves are used rather than
acoustic waves. Ultrasound
sends out waves of sound and
interprets the echoes reflected
back by structures to create a
visual image. A ship's sonar, for
example, reveals the ragged
terrain of the ocean far below
it. Similarly, OCT shines a
beam of infrared light into
tissue structure, and its backreflections, measured from
different positions, form an
image of the terrain within.
Thanks to OCT's high
resolution-10 times higher
than either clinical MRI or high
frequency ultrasound—
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Dr. Brezinki (left) with Prof. Fujimoto (right)
and members of their research team
School, and a Research Affiliate
in Electrical Engineering and
Computer Science at MIT. Coprincipal investigator is James
G. Fujimoto, Ph.D., Professor
in Electrical Engineering and
Computer Science at MIT.
The program for developing
OCT had two stages, the first
of which involved imaging of
transparent tissue. This began
in 1991. OCT imaging of the
retina provides a "very powerful
tool for ophthalmic diagnostics,
especially for conditions such as
glaucoma and macular edema,"
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The key advance described in
the article in Science is the
demonstration of OCT for
imaging nontransparent tissue
in vivo. In the article, the
researchers used OCT to image
the esophagus of a living rabbit.
"This advance opens up the
possibility of an incredibly
broad range of clinical applications," adds Prof. Fujimoto.
Developing OCT to its current
status required persistence and
an effective collaboration
among researchers. "Three and
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one-half years ago, I was told by
many people that this project
wouldn't work, that light
wouldn't penetrate deeply
enough. Now we are just about
ready to test OCT in patients
through a high-speed, highresolution catheter/
endoscope-based system," says
Dr. Brezinski.
"This could not have been
accomplished by one or two
individuals but represented the
vertical integration of students,
postdoctoral fellows, and investigators, a fact of which we are all
very proud. If you compare this
to other technologies like
ultrasound and MRI, we have
come a tremendous way in three
and one-half years."
The researchers suggest that
OCT will replace conventional
biopsy for many applications in
the future. First, OCT can be
used where conventional biopsy
would be hazardous, the brain
and coronary arteries being the
most prominent examples.
Second, OCT could serve well
where surgical biopsy misses the
diagnosis, such as in early cancer
detection in the colon,
esophagus, and cervix. Third,
they suggest OCT can be used to
guide surgical and microsurgical
procedures such as nerve repair
or prostate surgery.
Now, Brezinksi and colleagues
are working directly with
patients, increasing the
resolution to allow OCT to be
applied to early diagnosis of such
disorders as cervical cancer, and
exploring technologies to use
with OCT, such as spectroscopy,
which may allow biochemical as
well as structural information to
be gained from tissue.
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CLASS NOTES
his J.D. during those same years
from Rutgers Law School in
Camden and is now doing a
residency in internal medicine at
Cooper Hospital/University Medical
Center. Dr. Conaway recently
married Kathleen Heintz and has a
wonderful two-year-old daughter,
Alexandria.
David W. Dinwiddie and his wife,
Maria Alaimo-Dinwiddie '90, of
Encino, CA proudly announce the
birth of their second child, Gina
Rose, born August 23, 1997. Their
first child, David Sal, is four years
old and very happy to be a big
brother.
'90
P. Kurt Bamberger of Silver Spring,
MD received the General Graves B.
Erskine Award as an outstanding
graduating general surgery resident.
His mentors wrote, "Dr. Bamberger
has excelled in the clinical care of
the most complex patients. He is

Bermuda in June 1998
As part of their 50th Reunion celebration the Class of '48 is
going to Bermuda June 7-11, 1998. They cordially invite other
Jefferson alumni and friends to go with them.
For information and reservations kindly contact:

s inthrop F. Whitcomb

National Association of
Inpatient Physicians, which
has a data base on "over 1,000
hospitalists." Dr. Whitcomb is
also Course Director for the
association's first annual
meeting to be held April 1,
1998 in San Diego. He is
Medical Director of the Mercy
Internal Medicine Service at
Mercy Hospital, a 200-bed
community hospital in
Springfield, Massachusetts.
This service is fairly typical of
the hospitalist concept. He
explains, "It provides
inpatient medical care for
patients referred from outside
physicians or those without
physicians. Additionally, the
service admits all internal
medicine cases and handles all
floor emergencies between 11
P.M. and seven A.M., allowing
the on-call community
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Michael E. Lekawa of Tustin, CA
completed his fellowship in surgical
critical care at UC Irvine. He is now
an Assistant Professor of Surgery
there, and Director of Trauma and
Critical Care. He and his wife, Sajee,
have a three-year-old daughter named
Serena.

Gail Pensabene (Travel Agent)
Spring House Travel Village Center
Spring House, PA 19477
Phone: 215-643-7074 Fax: 215-643-6737

'91

A $300 deposit is required by January 31 to hold a seat.
It will be a wonderful trip! Hope you can come.
widely respected throughout the
Department of Surgery for his mature
judgment and devotion to all details
of the management of patients."
Jeffrey M. Hoffman of Boca Raton, FL
recently married and is a member of
the medical staff of St. Mary's
Hospital, Pediatric Emergency
Department, in West Palm Beach, FL.

Whitcomb Active "Hospitalise"
V\t '89 is co-founder of the

Sinai Medical Center, New York City,
Division of General Internal Medicine.

internists to sleep at night.
Currently our 'hospitalise group
employs six physicians full-time
and several part-time. The first
challenge in establishing the
service was to gain acceptance
by the hospital's medical staff
of community practitioners.
"The concept responds to the
need to maximize efficiency of
medical care. It eliminates the
time formerly spent by
outpatient physicians
commuting to and from the
hospital. Instead, the hospitalist
is always on site. Most
hospitalists are salaried
employees of an HMO or
hospital, but some work as
their own practice in a fee-forservice model."
The "hospitalist" concept was
succinctly described by
Wachter and Goldman in the
New England Journal of
Medicine, August 15, 1996, at
page 514.
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Wayne B. Bauerle of Myrtle Beach,
NC has joined the orthopaedic
surgery department at Grand Strand
Regional Medical Center.

Melanie S. Kelton-Landau of New
York, NY and husband David are
thrilled to announce the birth of
their first child. Andrew Benjamin
was born May 1, 1997. Melanie is
currently on the faculty of the Mt.

Stanley C. Marczyk of Cranberry
Township, PA has completed his
fellowship in hand and upper
extremity surgery at Allegheny
General Hospital in Pittsburgh. He is
entering into private practice in South

Please submit news for Class Notes to:
Attention: Alumni Bulletin
Jefferson Medical College of Thomas Jefferson University
1020 Locust Street, Suite M-41
Philadelphia, PA 19107-6799
Fax: 215 923 9916 Attention: Alumni Bulletin
E-mail: Malcolm.Clendenin@mail.tju.edu
World Wide Web site:
http://jeffline.tju.edu/CWIS/JMC/alumnilbulletin.html
Would you like to contact the Alumni Office electronically?
Send information such as address changes or personal and
professional changes to: jmcalums@jeflin.tju.edu
ta,

Readers are encouraged to submit nominations for:
1) Alumni Trustee of Thomas Jefferson University: One is
elected each year for a three-year term (he or she may be
reelected for one additional term). Please submit names of
worthy candidates to "Attention: Alumni Trustee Committee,"
1020 Locust Street, Suite M-41, Philadelphia, PA 19107.
2) Alumni Achievement Award: Although the award carries
no monetary stipend, each recipient's name is permanently
affixed to a plaque prominently displayed at the entrance to
Jefferson Alumni Hall. The recipient is presented with a
handsome silver tray, suitably engraved and bearing the seal
of the medical college, as the highlight of the Alumni Banquet
each June. The Achievement Award Committee of the Alumni
Association is charged with the final selection; the committee's
decisions are not subject to review. Please direct curricula
vitae and bibliographies of alumni whose professional
activities are sufficiently outstanding to warrant consideration
to "Attention: Achievement Award Committee,"
1020 Locust Street, Suite M-41, Philadelphia, PA 19107.
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Jersey with Atlantic Shore
Orthopaedic Associates. He and his
wife, Mara, proudly announce the
birth of their second son, Matthew
Ryan, born March 18, 1997. Their
oldest son, Stanley (Stash) Patrick,
is two and one-half.
Lawrence C. Rosenbaum of Aptos,
CA is practicing internal medicine
in Santa Cruz, CA. He and his wife,
Amy, are enjoying life with their
son, Zachary Isaac, born July 2,
1996.
'92
David L. Carter of Elizabeth City,
NC is one of the newest members of
the Carolina Surgical Care team
working out of Gates County
Medical Center. He and two others
are responsible for general, thoracic,
and vascular surgery in the
Elizabeth City and Kitty Hawk
offices.
Scot R. McKenna of Philadelphia,
PA completed a five-year general
surgery residency at Mercy Hospital
of Pittsburgh. He finished as chief
resident in June and was the
recipient of the Albert G.
Marrangoni, M.D. Surgical Research
Award. While at Mercy Hospital,

Join the Alumni
for a Jefferson Update
Plan to attend a presentation on
The State of Thomas Jefferson University
and Jefferson Medical College
by Paul C. Brucker, M.D.
President, Thomas Jefferson University
Joseph S. Gonnella, M.D.
Senior Vice President for Academic Affairs, Thomas Jefferson
University, and Dean, Jefferson Medical College
Joseph W. Sokolowski Jr. '62
President, Jefferson Medical College Alumni Association
Thursday, February 5, 1998
Solis-Cohen Auditorium, Jefferson Alumni Hall
5:00 until 6:00
light collation immediately following

Dr. McKenna participated in multiple
research projects and presented his
work on burn treatment at conferences in the United States, Argentina,
and Colombia. He has begun a plastic
surgery residency at Temple
University Hospital.

Berger Studies Possible
Prion Disease from Squirrels
oseph R. Berger '74
) received considerable media
attention in September for his
observation on a possible
relationship between
Creutzfeldt-Jakob disease (a
prion disease in humans that is
similar to "mad cow" disease)
and eating squirrel brains, a
not uncommon food in
Kentucky. Dr. Berger is
Professor and Chairman of
Neurology at the University of
Kentucky College of Medicine.

Prion diseases spread through
the ingestion of infected
tissue. Mad cow disease seems
to have spread through British
herds when cattle were fed
protein supplements made
from the ground-up body
parts of other cattle that
were infected.

As for the possible danger of
infected squirrels, not only the
brain but any part of a diseased
animal could theoretically
transmit a prion condition
In the August 30 issue of Lancet, to a human who ate it.
Dr. Berger was the first of three
Dr. Berger notes that the
authors on "Creutzfeldt-Jakob
study is still preliminary;
Disease and Eating Squirrel
the researchers are currently
Brains." The discovery made
increasing their epidemiologic
the pages of Newsweek and the
survey.
Associated Press.
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'93 Fifth Reunion June 6
Eric R. Mariotti and his wife, Deb,
of Louisville, KY proudly
announce the birth of David
Matthew, born June 18, 1997. Dr.
Mariotti is doing a fellowship in
plastic and reconstructive surgery.
Antonio J. Ripepi of Cleveland
Heights, OH has begun a
fellowship
in minimally invasive surgery at
the Cleveland Clinic.
John T. Tong of Los Angeles, CA
has completed his residency at the
Jules Stein Eye Institute in Los
Angeles and will specialize in
pediatric ophthalmology. This is a
fine tribute to Leonard Apt '45
who is a mentor for Dr. Tong.
'94
Jeffrey G. Adams of Quincy, MA
and his wife, Kimberly, proudly
announce the birth of their first
child, Brea, born July 10, 1997.
Carole D. Levy and her husband,
David, of Wallingford, PA proudly
announce the birth of a baby boy,
Jacob Benjamin.
Holli S. Pheasant of Lansdowne,
PA married John Viscusi Jr. in May
1997.
Daniel S. Rifkin of Merion, PA is a
fellow in pediatric pulmonology at
St. Christopher's Hospital for
Children.
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'95
Susheel P. Patil of Shaker Heights,
OH will become Chief Resident in
internal medicine at the University
of Cleveland. He plans to specialize
in pulmonary/critical care medicine.
Paul R. Stauffer, a second-year
surgical resident from York, PA,
was part of the York Medical
Mission which traveled to the
poorest part of India, Chamba, in
the foothills of the Himalayas. This
was Dr. Stauffer's third trip. He
spent one year there studying the
Hindi language, among other
things.
A United Nations' organization,
Impact India, had arranged for
patients to gather in Chamba. Many
had traveled for days just to be
treated by one of the health professionals.
The medical team was made up
of nurses, an anesthesiologist, and
eight doctors, including a plastic
surgeon, a gynecologist, and an ear,
nose, and throat specialist. The
team had to bring much of their
own supplies.
'96
Andrew Kwak and his wife, Gina, of
Wynnewood, PA joyfully announce
the birth of their daughter, Kyra
Lee, on June 14, 1997. Andrew is a
first-year radiology resident at
Jefferson.
'97
JenniferJo Dischel of Ashland, MA
is an Air Force captain, and was the
only doctor on Air Force Two when
it carried Vice President Al Gore to
a day-long visit in Boston. Jennifer
is serving an internship as a flight
surgeon at Andrews Air Force Base,
MD, where Air Force One and Two
are based.
Postgraduate Alumni
Marc L. Schwartz IM'81 of
Philadelphia was elected President
of the Medical Staff at Jefferson for
the July 1997 through June 1999
term.
Anne Marie C. Angeles D'91 of
Merion, PA has been appointed
Instructor in Dermatology and
Cutaneous Biology at Jeff.
ToddJ. Albert ORS'92 of Merion,
PA has been appointed Associate
Professor of Orthopaedic Surgery.
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ANNOUNCEMENT
URING the past few years Jefferson
Alumni have repeatedly requested
the publication of a bulletin to
contain news of the College and Hospital
and of the activities of graduates in various portions of the world. There can be
no doubt that many things of interest
are happening daily, and the alumni of
Jefferson should know of these happenings. Moreover, alumni should be in
closer touch with the College. This first

D

edition of the Alumni Bulletin inaugurates the policy of acquainting the
alumni with the latest news concerning
Jefferson. If the interest and support on
the part of the alumni are sufficiently
encouraging, additional bulletins will be
issued from time to time. Expressions
of opinion concerning the desirability
and future character of the Bulletin
should be addressed to the Committee.

A Letter from the President of the Board of Trustees
to the Corresponding Secretary of the
Alumni Association
T a meeting of the Executive Committee of the Alumni Association
on August 25, 1922, the opinion
was expressed by several members present that there still existed an impression
among certain of the alumni that Jefferson might ultimately merge with the
University of Pennsylvania. The Executive Committee passed a resolution that
the Alumni Bulletin should contain a
statement from the Board of Trustees in
regard to the matter of merger. A letter
was addressed to Mr. Potter, President
of the Board of Trustees, who replied as
follows:

A

"Dear Dr. Funk:
"Yours of the 16th inst. received. It is
Indeed amazing that there should exist
in the mind of any Jefferson alumnus,
the thought that there might still be a
merger with any friendly rival institution of medicine.
"The administration of Jefferson Medical College is unanimous that we continue as the great independent medical
school of the United States, whose fame

is national and international. The Jefferson doctor passes more State Boards,
and the number of living graduates of
Jefferson is greater than that of any
other medical college.
"I can conceive of no change in this
fixed policy unless unhappily the alumni
of Jefferson should cease to continue a
vital interest in their distinguished Alma
Mater.
"The Jefferson Medical College possesses famous traditions and men who
are 'carrying on.' One of our pressing
needs now, however, is more and more
money to keel) abreast with friendly but
formidable rivals. We have, in the past.
with the spur of poverty back of us, kept
abreast of this rivalry and God willing,
if our large alumni, scattered all over the
world, will add to their own interest, the
interest of their friends, Jefferson will
maintain her present most enviable
position.
"Yours faithfully,
"WILLIAM POTTER.
"President, Board of Trustees."

